Antigens of the virion of the HEPATITIS B VIRUS or the Dane particle, its surface (HEPATITIS B SURFACE ANTIGENS), core (HEPATITIS B CORE ANTIGENS), and other associated antigens, including the HEPATITIS B E ANTIGENS.
INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum.
Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen.
INFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water.
Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens.
INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
A technique that combines protein electrophoresis and double immunodiffusion. In this procedure proteins are first separated by gel electrophoresis (usually agarose), then made visible by immunodiffusion of specific antibodies. A distinct elliptical precipitin arc results for each protein detectable by the antisera.
Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some vaccines may be recombinantly produced.
Immunoelectrophoresis in which immunoprecipitation occurs when antigen at the cathode is caused to migrate in an electric field through a suitable medium of diffusion against a stream of antibody migrating from the anode as a result of endosmotic flow.
The hepatitis B antigen within the core of the Dane particle, the infectious hepatitis virion.
A closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G.
INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host.
Sensitive tests to measure certain antigens, antibodies, or viruses, using their ability to agglutinate certain erythrocytes. (From Stedman, 26th ed)
Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation.
Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen.
Substances that are recognized by the immune system and induce an immune reaction.
Technique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction.
Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1.
INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D).
INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.
The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed)
Pathological processes of the LIVER.
Substances elaborated by bacteria that have antigenic activity.
The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane.
A species in the genus HEPATOVIRUS containing one serotype and two strains: HUMAN HEPATITIS A VIRUS and Simian hepatitis A virus causing hepatitis in humans (HEPATITIS A) and primates, respectively.
A DNA virus that closely resembles human hepatitis B virus. It has been recovered from naturally infected ducks.
INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors.
Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis.
Substances elaborated by viruses that have antigenic activity.
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
Immunoglobulins produced in response to VIRAL ANTIGENS.
A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species.
Vaccines or candidate vaccines used to prevent infection with hepatitis A virus (HEPATOVIRUS).
Deoxyribonucleic acid that makes up the genetic material of viruses.
Antibodies to the HEPATITIS C ANTIGENS including antibodies to envelope, core, and non-structural proteins.
Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes.
Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.
INFLAMMATION of the LIVER in animals due to viral infection.
INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS, a defective RNA virus that can only infect HEPATITIS B patients. For its viral coating, hepatitis delta virus requires the HEPATITIS B SURFACE ANTIGENS produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated.
Sets of cell surface antigens located on BLOOD CELLS. They are usually membrane GLYCOPROTEINS or GLYCOLIPIDS that are antigenically distinguished by their carbohydrate moieties.
Any of the viruses that cause inflammation of the liver. They include both DNA and RNA viruses as well viruses from humans and animals.
Any vaccine raised against any virus or viral derivative that causes hepatitis.
A reverse transcriptase inhibitor and ZALCITABINE analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat HIV disease.
Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases.
A defective virus, containing particles of RNA nucleoprotein in virion-like form, present in patients with acute hepatitis B and chronic hepatitis. It requires the presence of a hepadnavirus for full replication. This is the lone species in the genus Deltavirus.
Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen.
Acute INFLAMMATION of the LIVER in humans; caused by HEPATITIS E VIRUS, a non-enveloped single-stranded RNA virus. Similar to HEPATITIS A, its incubation period is 15-60 days and is enterically transmitted, usually by fecal-oral transmission.
Antibodies to the HEPATITIS A ANTIGENS including antibodies to envelope, core, and non-structural proteins.
A positive-stranded RNA virus species in the genus HEPEVIRUS, causing enterically-transmitted non-A, non-B hepatitis (HEPATITIS E).
A chronic self-perpetuating hepatocellular INFLAMMATION of unknown cause, usually with HYPERGAMMAGLOBULINEMIA and serum AUTOANTIBODIES.
A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
A strain of HEPATITIS A VIRUS which causes hepatitis in humans. The virus replicates in hepatocytes and is presumed to reach the intestine via the bile duct. Transmission occurs by the fecal-oral route.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Tumors or cancer of the LIVER.
Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
INFLAMMATION of the LIVER in non-human animals.
An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC
Sites on an antigen that interact with specific antibodies.
A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.
Ribonucleic acid that makes up the genetic material of viruses.
Class I human histocompatibility (HLA) surface antigens encoded by more than 30 detectable alleles on locus B of the HLA complex, the most polymorphic of all the HLA specificities. Several of these antigens (e.g., HLA-B27, -B7, -B8) are strongly associated with predisposition to rheumatoid and other autoimmune disorders. Like other class I HLA determinants, they are involved in the cellular immune reactivity of cytolytic T lymphocytes.
An ORTHOHEPADNAVIRUS causing chronic liver disease and hepatocellular carcinoma in woodchucks. It closely resembles the human hepatitis B virus.
Antigens produced by various strains of HEPATITIS D VIRUS.
One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells. In addition to antiviral activity, it activates NATURAL KILLER CELLS and B-LYMPHOCYTES, and down-regulates VASCULAR ENDOTHELIAL GROWTH FACTOR expression through PI-3 KINASE and MAPK KINASES signaling pathways.
Antigens of the virions of HEPACIVIRUS, their surface, core, or other associated antigens.
Antigens from any of the hepatitis viruses including surface, core, and other associated antigens.
The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle.
The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
Polymorphic class I human histocompatibility (HLA) surface antigens present on almost all nucleated cells. At least 20 antigens have been identified which are encoded by the A locus of multiple alleles on chromosome 6. They serve as targets for T-cell cytolytic responses and are involved with acceptance or rejection of tissue/organ grafts.
A genus of PICORNAVIRIDAE causing infectious hepatitis naturally in humans and experimentally in other primates. It is transmitted through fecal contamination of food or water. HEPATITIS A VIRUS is the type species.
The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B.
Any part or derivative of any protozoan that elicits immunity; malaria (Plasmodium) and trypanosome antigens are presently the most frequently encountered.
Antibodies produced by a single clone of cells.
A species of the CORONAVIRUS genus causing hepatitis in mice. Four strains have been identified as MHV 1, MHV 2, MHV 3, and MHV 4 (also known as MHV-JHM, which is neurotropic and causes disseminated encephalomyelitis with demyelination as well as focal liver necrosis).
EPIDEMIOLOGIC STUDIES based on the detection through serological testing of characteristic change in the serum level of specific ANTIBODIES. Latent subclinical infections and carrier states can thus be detected in addition to clinically overt cases.
Carbon-containing phosphonic acid compounds. Included under this heading are compounds that have carbon bound to either OXYGEN atom or the PHOSPHOROUS atom of the (P=O)O2 structure.
Antigens produced by various strains of HEPATITIS A VIRUS such as the human hepatitis A virus (HEPATITIS A VIRUS, HUMAN).
Established cell cultures that have the potential to propagate indefinitely.
Polyomavirus antigens which cause infection and cellular transformation. The large T antigen is necessary for the initiation of viral DNA synthesis, repression of transcription of the early region and is responsible in conjunction with the middle T antigen for the transformation of primary cells. Small T antigen is necessary for the completion of the productive infection cycle.
The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS.
Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation.
The type species of the genus MARDIVIRUS in the family HERPESVIRIDAE. It is the etiologic agent of MAREK DISEASE, infecting domestic fowl and wild birds.
Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis.
Proteins found mainly in icosahedral DNA and RNA viruses. They consist of proteins directly associated with the nucleic acid inside the NUCLEOCAPSID.
The processes triggered by interactions of ANTIBODIES with their ANTIGENS.
A genus of Sciuridae consisting of 14 species. They are shortlegged, burrowing rodents which hibernate in winter.
An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed.
Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen.
Substances of fungal origin that have antigenic activity.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
The major group of transplantation antigens in the mouse.
Virus diseases caused by the HEPADNAVIRIDAE.
Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens.
Any part or derivative of a helminth that elicits an immune reaction. The most commonly seen helminth antigens are those of the schistosomes.
INFLAMMATION of the LIVER due to ALCOHOL ABUSE. It is characterized by NECROSIS of HEPATOCYTES, infiltration by NEUTROPHILS, and deposit of MALLORY BODIES. Depending on its severity, the inflammatory lesion may be reversible or progress to LIVER CIRRHOSIS.
A purine base and a fundamental unit of ADENINE NUCLEOTIDES.
The quantity of measurable virus in a body fluid. Change in viral load, measured in plasma, is sometimes used as a SURROGATE MARKER in disease progression.
The transference of a part of or an entire liver from one human or animal to another.
The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site.
A nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses.
A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally being called a macroglobulin.
The complete genetic complement contained in a DNA or RNA molecule in a virus.
Proteins prepared by recombinant DNA technology.

Third component, HBeAg/3, of hepatitis B e antigen system, identified by three different double-diffusion techniques. (1/499)

A third component, HB(e)AG/3, of the hepatitis B e antigen system has been detected, and it was consistently detected in three variations of the double-diffusion technique.  (+info)

Hepatitis virus infection in haemodialysis patients from Moldavia. (2/499)

BACKGROUND: Although the epidemiology of hepatitis B (HBV) and C (HCV) now seems well established for Western European countries, in Central and Eastern Europe < 50% of all dialysis centres routinely test for hepatitis C antibodies since testing is not available or is not applied to all patients. This study describes the prevalence, risk factors and clinical significance of HBV and HCV infection for the haemodialysis population of the North Eastern region of Romania, Moldavia. METHODS: The presence of HBV antigens was determined with an ELISA kit (Wellcome, Abbot) and HCV antibodies with the ELISA-3 Ortho-HCV, third generation test. The following individual data were collected: gender, age, duration of dialysis, rural/urban domicile, actual and previous HBV status, actual HCV status, known acute, clinically evident hepatitis episodes in the last 3 years, monthly alanine aminotransferase (ALAT) and aspartate aminotransferase (ASAT) levels, complete biochemical hepatic assessment at the time of the study, transfusions for the past 3 years and family history. RESULTS: HBV and HCV prevalences were 17% (stable over the last 3 years) and 75%, respectively; co-infection was seen in 10% of the subjects. Hospitalization (nosocomial infection) for HBV, blood transfusions and duration on dialysis for HCV, emerged as the main risk factors for hepatitis infection. Socio-economic conditions appear to be equally important for HCV infection, since the prevalence was significantly higher among patients from rural, underdeveloped areas than urban areas (80.8 vs 60.3%), and infection was already present in a large proportion of patients (47%) before starting dialysis, without being related to previous disease duration or blood transfusions. HBV and/or HCV was not associated with a worse clinical or biochemical profile at the time of the study. However, infected patients had significantly more previous cytolytic episodes, with higher, transient increases in ALAT and ASAT levels. CONCLUSIONS: HCV infection is endemic among dialysis centres in Moldavia. Apart from previously well-known risk factors for hepatitis infection, our study demonstrates the negative impact of socio-economic underdevelopment. Simple measures such as enforced general asepsia rules, careful disinfection and equipment sterilization, routine testing of patients from economically disadvantaged areas and monthly, serial determination of hepatic enzymes should be the common practice in dialysis centres in Romania.  (+info)

Human hepatitis B virus X protein is detectable in nuclei of transfected cells, and is active for transactivation. (3/499)

Subcellular localization and transactivation of human hepatitis B virus X protein (HBx), a plausible causative factor for hepatocellular carcinogenesis, were studied in transiently transfected cells. The transactivation was detected not only by the cis-element driven chloramphenicol acetyltransferase (CAT) assay but also by immunostaining of CAT protein cotransfected into human hepatoma cell line HepG2. Scanning fluorescence microscopy showed the majority of immunological signals of HBx to be at the perinuclear region of transfected cytoplasm. HBx was also clearly detectable in the nucleus, though less intensely expressed. This was confirmed by Western analysis and coimmunoprecipitation of HBx with transcription factor IIB (TFIIB) in subcellular fractionations. The percentage of HBx-positive cells coincided with that of CAT-positive cells, and confocal laser microscopy revealed the coexistence of CAT signals in GFP-HBx positive cells. The SV40 large T antigen nuclear localization signal (NLS) appended HBx, regardless of whether NLS was added to the N- or C-terminus, transactivated all the examined X-responsive elements (XRE) similarly as did wild-type HBx. Similar results were obtained in p53 negative Saos-2 cells. The detected nuclear HBx may be involved in modulating the transcription at the promoter level whereas the HBx in cytoplasm may be working through signal transduction pathways.  (+info)

HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-inflammatory cytokines. (4/499)

The aim of this study was to examine the immunomodulating effects of rhIL-12 on the immune response induced by hepatitis B virus (HBV) antigens in clinical subgroups of patients with HBV infection. Peripheral blood mononuclear cells (PBMC) of 80 patients were stimulated with HBsAg, HBcAg, pre-S1Ag and tetanus toxoid in the absence or presence of IL-12 (0.01, 0.1 and 1 ng/ml). Stimulation by anti-CD3+ anti-CD28 and lipopolysaccharide (LPS) were used as controls. Proliferation and cytokine production were determined by 3H-thymidine uptake and ELISA after 72 h. After stimulation with HBV antigens only, production of tumour necrosis factor-alpha (TNF-alpha) or IL-10 was observed in all patients, while interferon-gamma (IFN-gamma) was detectable in only 27 patients. After costimulation with IL-12 and HBV antigens, however, large amounts of IFN-gamma were found in all patients, while HBV-induced IL-10 production remained mostly unchanged. When clinical subgroups including patients with compensated liver cirrhosis were compared, PBMC from patients with HBeAg+ hepatitis showed the lowest capacity to produce IFN-gamma after HBV antigen-positive IL-12. These data suggest that the ability of IL-12 to enhance IFN-gamma production against HBV antigens is correlated with the presence of HBeAg and is not impaired in patients with advanced liver disease. In addition, IL-12 and IL-10 production by antigen-presenting cells may be a critical factor that determines the efficacy of the immune response against the hepatitis B virus.  (+info)

The hepatitis B pX protein promotes dimerization and DNA binding of cellular basic region/leucine zipper proteins by targeting the conserved basic region. (5/499)

The hepatitis B virus pX protein is a potent transcriptional activator of viral and cellular genes whose mechanism of action is poorly understood. Here we show that pX dramatically stimulates in vitro DNA binding of a variety of cellular proteins that contain basic region/leucine zipper (bZIP) DNA binding domains. The basis for increased DNA binding is a direct interaction between pX and the conserved bZIP basic region, which promotes bZIP dimerization and the increased concentration of the bZIP homodimer then drives the DNA binding reaction. Unexpectedly, we found that the DNA binding specificity of various pX-bZIP complexes differs from one another and from that of the bZIP itself. Thus, through recognition of the conserved basic region, pX promotes dimerization, increases DNA binding, and alters DNA recognition. These properties of pX are remarkably similar to those of the human T-cell lymphotrophic virus type I Tax protein. Although Tax and pX are not homologous, we show that the regions of the two proteins that stimulate bZIP binding contain apparent metal binding sites. Finally, consistent with this in vitro activity, we provide evidence that both Tax and pX activate transcription in vivo, at least in part, by facilitating occupancy of bZIPs on target promoters.  (+info)

HBV and proteinuria in relatives and contacts of children with hepatitis B virus-associated membranous nephropathy. (6/499)

BACKGROUND: Hepatitis B virus (HBV)-associated membranous nephropathy (HBVMN) is an important cause of childhood nephrotic syndrome in regions endemic for the virus, but little is understood of the biosocial context in which the disease develops. We evaluated HBV status and proteinuria in family members and household contacts of index children with HBVMN to test the hypothesis that HBV carriage and asymptomatic proteinuria are closely linked and may be causally associated. METHODS: Thirty-one black children with biopsy-proven HBVMN were the index cases. One hundred and fifty-two family members and 43 black household contacts were the subjects of the study. We assessed HBV carrier status by testing for HBV antigens and antibodies using enzyme-linked immunosorbent assays (ELISA) and for HBV DNA by using slot-blot hybridization and the polymerase chain reaction. Sequencing of the precore region of HBV was done in a subset of both index cases and subjects. Proteinuria was assessed by measuring the urinary protein/creatinine ratio. RESULTS: Seventy-two (37%) of the 195 family members and household contacts were HBV carriers, and 53 (27%) had a protein/creatinine ratio greater than the physiological limit. The frequency of abnormal proteinuria was not significantly different in those with [22 out of 72 (30.5%)] or without [33 out of 104 (32%)] HBV carriage. This lack of association remained when carriers were classified into those who were HBsAg positive only and those with active viral replication (HBsAg and/or HBeAg and/or HBV DNA; P = 0.01). Family members were more predisposed to HBV carriage than household contacts, but abnormal proteinuria was present with equal frequency (P = 0.48). Age had a significant impact on proteinuria, with children less than five years being more likely to have abnormal proteinuria (P = 0.008). The prevalence of abnormal proteinuria in family members and household contacts of the index cases was more than that in community-based controls. The 10 index HBVMN cases and the 14 family members and household contacts who were tested all had HBV of genotype A. CONCLUSION: These results suggest that the family members and household contacts of children with HBVMN are at very high risk of HBV carriage; they also have asymptomatic proteinuria at a significantly higher rate than community-based controls. The HBV carrier status was not associated with proteinuria, a finding supported by peak prevalences of proteinuria in those under five years but no corresponding peak for HBV carriage. Proteinuria may indicate glomerular basement membrane dysfunction. Environmental and social factors may underpin development of these two covert disorders, but are insufficient to account for the index cases of HBVMN. The emergence of children with HBVMN from such households additionally depends on unidentified and possibly genetic factors.  (+info)

The proapoptotic effect of hepatitis B virus HBx protein correlates with its transactivation activity in stably transfected cell lines. (7/499)

The role of hepatitis B virus HBx protein in the carcinogenesis associated with chronic viral infection remains ill-defined. Indeed, pleiotropic effects have been ascribed to HBx: in addition to its well-documented ability to indirectly stimulate transcription, the protein has been reported to affect cell growth, signal transduction, DNA repair and apoptosis. In this work, we generated Chang (CCL-13)-derived cell lines constitutively expressing wild type or mutant HBx, as a model of HBx-host cell interaction closer to the chronic infection setting, than the classically used transient expression systems. We document the potentiation by HBx of the apoptotic cell death pathway in the recipient cells. This effect is unlikely to rely on p53 activity since the protein is functionally inactivated in CCL-13. In addition, antioxidants and cyclosporin A failed to reduce the apoptotic response back to the normal level, suggesting that production of reactive oxygen species and calcineurin activation are not directly involved in the proapoptotic effect of HBx. In contrast, our data show that transactivation and stimulation of apoptosis are tightly linked HBx activities. Finally, expression of transactivation-active protein did not result in detectable change in the pattern of MAP kinases phosphorylation nor did it affect the ability of the host cell to repair in vitro irradiated plasmid DNA.  (+info)

Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations. (8/499)

The major risk factors for hepatocellular carcinomas (HCC) in high incidence areas include infection with hepatitis B and C viruses (HBV, HCV) and exposure to aflatoxin. Genetic alterations in 24 liver resection specimens from Shanghai and Qidong were studied. Hepatitis B virus was integrated in all patient samples, and a null phenotype for the GSTM1 enzyme was present in 63% of patients. Alteration of p53 was present in 95% (23/24) of cases: mutations of the p53 gene in 12 HCC, p53 overexpression in 13 and loss of heterozygosity (LOH) of chromosome 17p in 17. All seven HCCs with a p53 mutation from Qidong and three of five from Shanghai had the aflatoxin-associated point mutation with a G to T transversion at codon 249, position 3. No HCC had microsatellite instability. LOH of chromosome 4q, 1p, 16q and 13q was present in 50%, 46%, 42% and 38%, respectively, and 4q was preferentially lost in HCCs containing a p53 mutation: LOH of 4q was present in 75% (9/12) of HCC with, but only 25% (3/12) of HCC without, a p53 gene mutation (P = 0.01). These data indicate a possible interaction between p53 gene mutation and 4q loss in the pathogenesis of HCC.  (+info)

The synthesis of Australia or hepatitis B antigen (HB Ag) is now considered to be the characteristic hallmark of infection by hepatitis B virus (HBV) and is therefore one of the most important criteria in the diagnosis of type B hepatitis. Hepatitis-B antigenic reactivity is associated with the surface of the spherical and tubular particles (20 nm in diameter) found in the serum of patients and carriers. The outer coat of the relatively rare 42-nm Dane particles also exhibits this HB-Ag reactivity, but their inner component or core is antigenically distinct. At the moment, the most credible claimants to the ...
Radioimmunnoassay was used to determine the serologic subspecificities of 85 blood donor serums positive for hepatitis B virus-associated antigen. There was complete agreement with results obtained by immunoprecipitatiotn of 43 serums. The remaining 42 serums were negative by immunoprecipitation but followed type-specific immunology by radioimmunoassay, and this served as a validation for authentic hepatitis B virus antigen. ...
Australia antigen definition: The definition of an australia antigen is a substance in the blood of some people with one form of hepatitus that causes the human body to make antibodies. (noun) HBsAg is the name of the surface molecule that is found in the blood ...
Arrowhead Research will host an analyst event today to discuss ARC-520, its RNAi-based candidate designed to treat chronic hepatitis B virus infection. The company will discuss the program and describe ...
Blood testing service Blue Horizon Medicals referring patients for Hepatitis B Antibodies (IgM) at private BMI hospitals in the UK
Bangkok, Thailand (PRWEB) October 3, 2007 -- Immureboost presented a product at the Therapies for Viral Hepatitis Symposium to Boston Scientists. The
We have emailed you at with instructions on how to set up a new password. If you do not receive an email in the next 24 hours, or if you misplace your new password, please contact:. ASA members: ...
490 blood samples have been examined for the comparison of the various methods concerned with the detection of the Australia Antigen (Au). The following methods have been comparatively examined: immunodiffusion (ID) counterelectrophoresis (CEP), complement fixation (CF) passive hemoagglutination (HA) and solid phase radioimmunoassay RIA. On the basis of the results so far obtained the RIA appears the most sensitive and specific method, followed by the HA. In order to obtain reproducible results for diagnostic purposes we suggest to carry out routinely two different techniques together (possibly RIA and HA), while for screening purposes just one technique, choosed between the two most indicative ones, shall be employed.
The Virological Department of the Hammersmith Hospital for the past two years has screened for the presence of Australia antigen (HAA) all candidates for admiss
Delta agent infection in Melbourne.: Evidence of infection with delta agent was sought in 284 patients with acute hepatitis B referred to Fairfield Hospital, Me
Vaccination by Banana New Scientist 96. BANANAS, genetically engineered to carry vaccines, could provide developing countries with a cheap way to protect children from life-threatening diseases, according to researchers in the US. Biotechnologists at the Boyce Thompson Institute for Plant Research an independent research centre at Cornell University in New York State, are genetically engineering a banana to produce an antigen found in the outer coat of the hepatitis B virus. Banana vaccines would be ideal for developing countries because they would cost just a few cents per dose, compared 10 the $100 to $200 per dose for traditional vaccines, says Charles Arntzen, president of the institute.. Last year, the team showed that hepatitis B antigens produced by genetically engineered potatoes triggered an immune response in rats. But because potatoes are not eaten raw, and cooking them would destroy the vaccine, tiley are unsuitable for vaccinating people. So the researchers switched their efforts to ...
Blood-borne type non-A, non-B (NANB) hepatitis-associated microtubular aggregates protein was isolated and partially sequenced. The microtubular aggregates were isolated from the hepatocytes of NANB-infected chimpanzees and were found to have a buoyant density in sucrose solution of 1.21 to 1.23 g/ml. A single protein, recognized by our anti-microtubular aggregates monoclonal antibodies, was found to have an M r of 44000 (p44). This p44 protein was not found in uninfected chimpanzees. We determined a partial amino acid sequence for p44, and showed that it has no homology to any known proteins.
Usha Rama College of Engineering and Technology, Usharama, Hepatitis-B, Hepatitis-B Seminar, Hepatitis-B Vaccination NSS Programme, NSS Programme, Usha Rama, Usha Rama College, URCE, B.Tech, Civil, CSE, ECE EEE, IT, ME, Events
What is the difference between A and B Antigens? Antigen A is found in people having blood group A and AB; antigen B is found in people having B and AB blood...
Gentaur molecular products has all kinds of products like :search , Exbio \ Mouse Monoclonal to HBV antigen HBsAg, Clone HB3, Isotype IgG1Application ICC, ELISA Concentration 1 mg ml \ 11-328-C025 for more molecular products just contact us
View mouse Cd79b Chr11:106311341-106314562 with: phenotypes, sequences, polymorphisms, proteins, references, function, expression
Last years Supercars parity saga nearly ruined the sport according to Triple Eight Race Engineering owner Roland Dane.. Speaking on the latest episode of Rustys Garage, Dane detailed his first glimpse of the then-new Ford Mustang that debuted at the VCAT test in late 2018.. He said Supercars was presented with a situation unprecedented in his time in the championship.. The other side turned up with a car that was just so radically different from anything that had been done before, we knew we were on the back foot, Dane told host Greg Rust.. But because Supercars as a category had never been placed in this position - or certainly in the 16 years that I had been around - then they didnt really know how to deal with it, which is totally different to how the landscape had been for the Ford versus Holden fight all the time I had been in Australia.. I would never say there havent been differences, but they were so small that other things had been more important. The team, the driver, etc. It ...
Dane Diagnostics ℗ Ltd was started in 1999 ,to be exact on july 11th 1999 We are completing 20 years of operations. Dane was the brain child of two pathologists ,Dr.Gowri and Dr.Sushama, both belong to palakkad.They wanted to bring the diagnostic tests hitherto unavailable at Palakkad ,their native place and there by give back something in return to the people of Palakkad
Download Brain Supercharger Cd11 Super Immunity Health by Spotts, Dane at! High Quality, Preview Available. Songs start at just $0.15!
Szampony do włosów, Chantal, Pollena ➤ porównanie cen ✓ opinie o produktach ✓ recenzje ✓ dane techniczne ➔ Szampony do włosów Chantal, Pollena porównaj ceny.
TY - JOUR. T1 - Proceedings. T2 - Cell-mediated immunity to hepatitis B antigen in antigen-negative active chronic hepatitis.. AU - Reed, W. D.. AU - Lee, W. M.. AU - Eddleston, A. L.. AU - Mitchell, C. G.. AU - Zuckerman, A. J.. AU - Williams, R.. PY - 1974/4/1. Y1 - 1974/4/1. UR - UR - M3 - Article. C2 - 4834574. AN - SCOPUS:0016054051. VL - 15. SP - 341. EP - 342. JO - Gut. JF - Gut. SN - 0017-5749. IS - 4. ER - ...
Antigens of the virion of the HEPATITIS B VIRUS or the Dane particle, its surface (HEPATITIS B SURFACE ANTIGENS), core (HEPATITIS B CORE ANTIGENS), and other associated antigens, including the HEPATITIS B E ANTIGENS ...
Hepatitis B Test NYC. Hepatitis B Antibody Test is FDA-approved hepatitis B test to look for hepatitis B infections. It cost $24.
TY - JOUR. T1 - Hepatitis B Virus. T2 - Inappropriate Reactions to Transmission Risks. AU - Kiernan, Thomas W.. AU - Powers, Robert J.. PY - 1979/2/9. Y1 - 1979/2/9. N2 - Ten patients designated as hepatitis B surface antigen (HBAg) carriers were screened for inappropriate reactions to their disease. Assessment with a 32-item questionnaire showed three carriers to have underreacted to the risks of HBAg transmission through misunderstandings or denial concerning the disease. One carrier, through severe social withdrawal, showed overreaction to the possibilities of disease transmission. Counseling was provided regarding the risks of HBAg transmission. At a one-month followup, all carriers appeared appropriately aware of the risks of transmission, and one of two carriers referred for psychotherapy showed greatly improved social adjustment. We recommend that persons treating HBAg carriers screen routinely for inappropriate reactions to risks of disease transmission and provide counseling as ...
Looking for online definition of CD49b antigen in the Medical Dictionary? CD49b antigen explanation free. What is CD49b antigen? Meaning of CD49b antigen medical term. What does CD49b antigen mean?
Abstract A series of Australia antigen-positive sera from healthy Nigerians was examined using the electron microscope. One serum was outstanding inasmuch as it contained a vast preponderance of the large 420 A Dane particles. Other sera exhibited the appearance accepted as the usual one in Australia antigen-positive sera. The significance of this variation in proportion of antigen forms is discussed and it is suggested that variations of this type could be of importance in prognosis.
In liver pathology, a ground glass hepatocyte, abbreviated GGH, is a liver parenchymal cell with a flat hazy and uniformly dull appearing cytoplasm on light microscopy. The cytoplasms granular homogeneous eosinophilic staining is caused by the presence of HBsAg. The appearance is classically associated with abundant hepatitis B antigen in the endoplasmic reticulum, but may also be drug-induced. In the context of hepatitis B, GGHs are only seen in chronic infections, i.e. they are not seen in acute hepatitis B. GGHs were first described by Hadziyannis et al. Several different types of GGHs are recognized: Type I - morphologically consist of GGHs that are scattered singly and have weak Pre-S2 positive immunostaining. Type II - morphologically consist of GGHs that are in clusters and have Pre-S2 negative immunostaining. There is some evidence to suggest that type II GGHs predispose to hepatocellular carcinoma. Drug reaction Mallory body Viral hepatitis Micrograph showing ground glass hepatocytes. ...
Misurac JM, VanDeVoorde RG, Kallash M, Iorember FM, Luckritz KE, Rheault MN, Jetton JG, Turman MA, Kapur G, Twombley KE, Hashmat S, Weaver DJ, Leiser JD, Nailescu C. Immunogenicity of Augmented Compared With Standard Dose Hepatitis B Vaccine in Pediatric Patients on Dialysis: a Midwest Pediatric Nephrology Consortium Study. Clin J Am Soc Nephrol. 2017 May 08; 12(5):772-778 ...
The AccuSet™ Anti-HBc/HBs Performance Panel is a 20-member validation panel of undiluted, naturally occurring plasma samples (1 vial per member, 1.5 mL per vial). Panel members represent bleeds from multiple individuals positive for antibodies to hepatitis B. Each sample represents a single collection event. No preservatives were added.. Test results from commercially-available hepatitis B antibody assays are included for characterization of the panel members. This panel of human plasma samples demonstrates reactivity ranging from negative to high positive for anti-HBc and anti-HBs. One sample is included as a non-reactive sample and is negative for all hepatitis B antibody test methods performed.. For Research Use Only. Not for use in diagnostic procedures.. ...
Corning® Fibronectin, human, 25mg (5 X 5mg), is used as a thin coating on tissue-culture surfaces to promote attachment, spreading, and proliferation of a variety of cell types. The principal functions of fibronectin appear to be in cellular migration during wound healing and development, regulation of cell growth and differentiation, and haemostasis/thrombosis. Quality Purity = 90% by SDS-PAGE Tested for ability to promote attachment and spreading of BHK-21 cells found negative for bacteria, fungi, and mycoplasma Source Human plasma. Source material tested for hepatitis B antigen and HIV-1 antibody. Molecular Weight 440 kD (unreduced form) Preparation and Storage Stable for three months at 2° to 8°C (lyophilized) or two weeks at -20°C (solubilized). Handling Recommended concentration - 1-5 µg/cm² of growth surface for coating or at 5 µg/ml as a media additive Formulation Lyophilized from CAPS buffer containing NaCl and CaCl2, pH 11.0
Australia antigen is the covering or capsule of HBV. Many a times an organism is identified on the basis of its covering thus similarly the presence of HBV in the body is often determined by its outside covering. It was first discovered in an Australian Tribal Man thus the name. Australia antigen is also called as “Hepatitis â€B Surface Antigen†(HBsAg).. ..., JAKARTA -- Mumi anak yang dikubur di Basilika Saint Domenico Maggiore, Naples, Italia pada 1980-an atau abad ke-16 sejauh ini dikenal sebagai kasus cacar paling awal yang ditemukan di dunia. Masalahnya, anak berusia dua tahun itu belakangan diketahui tidak terkena cacar air, menurut penelitian terbaru yang diterbitkan IFL Science. Ilmuwan kembali memeriksa sisa-sisa penemuan kuno yang masih merupakan studi penting dalam evolusi penyakit. Mumi anak tersebut tampaknya terkena hepatitis-B. Penemuan ini memberikan wawasan baru bagi peneliti tentang bagaimana virus tersebut berevolusi selama beberapa abad terakhir. Virus hepatitis-B atau HBV menyerang hati dan menyebabkan sirosis juga kanker hati. Virus ini menewaskan sekitar 887 ribu orang per tahun. Meski saat ini sebagian besar kasusnya bisa dicegah lewat vaksin, Organisasi Kesehatan Dunia (WHO) memperkirakan sekitar 257 juta orang di seluruh dunia hidup dengan HBV. Virus ini menyerang anak-anak,
Dane (Toddler/Little Kid) by See Kai Run Kids at Read See Kai Run Kids Dane (Toddler/Little Kid) product reviews, or select the size, width, and color of your choice.
We attracted a lot of people to our little group...the Danes being so big, and the Chis so small! What fun! And for such a great cause! The run was happening all across Canada today, and in our little region, we raised $500,000 today!!! Paws up to everyone ...
Danes, med brskanjem po, opazim novost. je po mnenju Pro Plusa nelinearni TV kanal?? In je namenjen izključno video vsebinam. Nekaj
Looking for online definition of Chronic Persistent Hepatitis in the Medical Dictionary? Chronic Persistent Hepatitis explanation free. What is Chronic Persistent Hepatitis? Meaning of Chronic Persistent Hepatitis medical term. What does Chronic Persistent Hepatitis mean?
BACKGROUND:. A baseline study on the vertical transmission of hepatitis B virus in Taiwan revealed that 15 percent of all pregnant women were persistent carriers of hepatitis B antigen and that 40 percent of their new babies developed a protracted antigenemia during the first 6 months of life. The incidence of acute hepatitis, cirrhosis, and hepatoma was high in Taiwan, and patients with these disorders had a fivefold to sixfold higher prevalence of hepatitis B antigen than healthy persons. Given the important public health problems of this disease in Taiwan and the rest of the Third World, this trial sought to answer the important question of whether hepatitis B immune globulin with a high level of antibody against the antigen would be of utility in combating the problem.. Two hundred and five babies were accepted into the study, which was actually conducted on Taiwan through a contract to the Community Blood Council of Greater New York. Only those babies born of mothers who had HBsAg ...
Blumberg BS. Alter HJ, Visoh S. A new antigen in leukaemias Sera. J. Am Med Assoc 1965: 191: -46 Malik IA. Luqman M. Ahmed A. Muzaffar M. Anwar CM, Akhtar MA. Qureshi MS. A clinicopathologic) study of viral hepatitis. Pak J Med Res. Vol.26, No. l. 1987. Kazmi K, Ghafoor A and Burney Ml. Prevalence of HBsAg among blood donors of Islamabad. Pak .1 Med Res, 1985; 24: 181-82. Malik IA, Legters U. Luqman M. Ahmed A. Qamar MA. Akhtar KAK, Qureshi MS, Duncaw F, Redfield RR. The serological markers of hepatitis A and B in healthy population of Northern Pakistan. JPMA. 1988; 69-72. Talukder MA, et al. Prevalence of Hepatitis-B surface antigen in male Saudi Arabians. J Inf Dis ; 146: 446. Hoofnagle JH. Viral hepatitis, in current concept of infectious disease. Edited by E.W. Hook et al New York. Willy, 1997; 243-61. Khuroo MS. Study of an epidemic of non-A. non B hepatitis; probability of another human hepatitis virus distinct from post-transfusion non-A, non-B type. AMI Med 1980; 68:818-24. Me Donald C, ...
Human plasma containing the Australia (hepatitis-associated) antigen was fractionated by the cold ethanol method of Cohn, Strong, Hughes, Mulford, Ashworth, Melin, and Taylor (1946) and small aliquots were examined for the presence of this antigen by immunodiffusion and by electron microscopy. The findings were in general agreement with the postulated risk of transmitting hepatitis by blood derivatives. The Australia (hepatitis-associated) antigen was detected in fibrinogen, thrombin, and antihaemophilic globulin as well as in other fractions. The antigen was not found in gamma globulin (immunoglobulin fraction) nor in albumin.. The use of radioiodinated fibrinogen for the diagnosis of deep vein thrombosis is discussed and it is concluded that the use of fibrinogen for diagnostic procedures should be assessed against the possible risk of hepatitis.. ...
Dane particle definition at, a free online dictionary with pronunciation, synonyms and translation. Look it up now!
ProdiGene was developing an edible vaccine against hepatitis B. The vaccine consists of transgenic corn expressing hepatitis B antigens and was in preclinical
Meaning: Hearing Aid Amplifier; Hemolytic Anemia Antigen; Hepatitis-associated Antigen; Hepatitis-associated Aplastic Anemia; Hospital Activity ...
Hearing Aid Amplifier; Hemolytic Anemia Antigen; Hepatitis-associated Antigen; Hepatitis-associated Aplastic Anemia; Hospital Activity ...
Hepatitis-B is reported with high incidence in Pakistan because of lack of awareness, causing morbidity and mortality among patients. This disease can be prevented through vaccination. Unfortunately, a large number of people cannot afford vaccination due to its cost.. In order to help those needy people, IMI Pakistans Karachi Chapter organized free vaccination camps at different areas. Like previous year, IMI Karachi teams, under the supervision of Dr. Hani and with support of other paramedical staff, set up a number of camps in different areas including Muhabat Nagar, Incholi, Jogi Mor Malir, Ammar-e-Yasir Society, Ayoub Goth, Paradise Medical & Emergency Centre and Gulshan-e-Hadeed. 1800 people throughout Karachi were vaccinated during these camps ...
Dear Sir, I have checked my blood for HBS Ag (Australia antigen) test on date 05.05.2013 for new job for foreign country. & result found Positive,Anti HCV IGM test found Non reactive. Kindly sugge...
An experienced Great Dane owner visits the Applicant and all their family, including all their animals, to see whether they understand the complexities of owning a Great Dane and aware of all its needs; also that they have the correct facilities for its welfare.. Transport… a Great Dane from its home and on to the Rescue facility.. If you have experience in handling Great Danes and own a Great Dane size vehicle, preferably with a caged door so that the Great Dane cannot escape whilst the main door is being opened, then we would appreciate your help. ...
The principle of the ABO system is that antigens - in this instance, sugars exposed on the surface of red blood cells - differ between individuals. People have immunological tolerance only for what occurs in their own bodies. As a result, humans may produce antibodies against natural components in the bodies of other people, but not themselves. So, people may produce antibodies against A and/or B antigens if they are not in their blood.. These antibodies clump red blood cells together if they carry the foreign antigens. This harsh response can cause death when large amounts of such cells are encountered after a blood transfusion. Because A and B antigens are chemically modified from a precursor form that is also present in type O individuals, people with type A and B antigens can accept blood from type O individuals.. Anti-A and anti-B antibodies are not present in the newborn. They appear in the first years of life. Anti-A and anti-B antibodies are usually too big to pass through the placenta ...
KEGG Orthology (KO) [BR:hsa00001] 09150 Organismal Systems 09151 Immune system 04662 B cell receptor signaling pathway [PATH:hsa04662] 974 CD79B; CD79b molecule K06507 CD79B; CD79B antigen 09180 Brite Hierarchies 09183 Protein families: signaling and cellular processes 04090 CD molecules [BR:hsa04090] 974 CD79B; CD79b molecule K06507 CD79B; CD79B antigen CD molecules [BR:hsa04090] Proteins 974 CD79B; CD79b molecule K06507 CD79B; CD79B antigen ...
Shantha Biotechs efforts were fructified in 1997. The company became the first Indian pharmaceutical unit to produce genetically engineered Hepatitis-B vaccine through indigenously developed technology. The vaccine, brand named SHANVAC-B, was so effective and economical, that the government of India showed interest in including this vaccine in its countrywide vaccination programmes to eradicate Hepatitis-B, alongwith Polio, Tetanus and Diphtheria. Successful development of Hepatitis-B vaccine brought several laurels to Shantha Biotech. The company was honoured with the All India Biotech Association (AIBA) Award-1997 for the ...
CD172b is a immunoglobulin-like cell surface receptor for CD47. CD172b supports adhesion of cerebellar neurons, neurite outgrowth and glial cell attachment.
Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in hepatitis B virus X antigen / Mi Kyung Chung; Hee Sik Yoon; Sung Shik Min; Hee Gu Lee; Young Jae Kim; Tae Gyu Lee; Jong Soon Lim; Chang Min Kim; Sue Nie Park , 1999 ...
Simply Dane DeHaan is an unofficial fansite and is not associated in any way with Dane, or any other official entity. This site is purely for fan-purposes. All images were obtained through public domain and will be taken down immediately upon requests of the respective owners and if any copyright laws were violated, it was unintentional ...
A paper published today with my collaborators shows a non-linear relationship between antibody response to a hepatitis-B vaccine and body height, with a positive relationship up to a height of 185 cm, but an inverse relationship in taller men. We did not find any significant relationship between body height and immune function in women. ...
Dont miss Eric Dane in the season finale of The Last Ship Sunday September 11th at 9PM on TNT! This interview aired on the KTLA Morning News on Tuesday September 6th, 2016.
See an archive of all Dane Dehaan stories published on the New York Media network, which includes NYMag, The Cut, Vulture, and Grub Street.
Vedeli ste, že možno máte nárok na refundáciu niektorej z daní, ktorú ste počas roka zaplatili? Naši odborníci na dane PAYE Vám pomôžu jednoducho online požiadať o maximálnu možnú daňovú refundáciu.
So, what kind of dog is Scooby Doo? Scooby-Doo is a fictitious character based on a male Great Dane. Iwao Takamoto, the characters creator, got his idea from another member of the Hanna-Barbera staff who happened to be a Great Dane breeder. Using their description as a starting point for Scooby-Doo, he tweaked some typical Great Dane qualities.
Danes na HBO - Bilo je nekoč v Mehiki, Ptice roparice (in fantastična osamosvojitev Harley Quinn), Alabamska kača, Lego Ninjago film, Čudežna varuška,...
Hepatitis B surface antigen. *Antibody to hepatitis C. *Antibody to HIV, usually subtypes 1 and 2 ... For example, the HIV antibody test will not detect a recently infected donor, so some blood banks use a p24 antigen or HIV ... The screening includes testing for diseases that can be transmitted by a blood transfusion, including HIV and viral hepatitis. ... and viral hepatitis. Screening may include questions about risk factors for various diseases, such as travel to countries at ...
Coleman, Paul F. (2017-02-17). "Detecting Hepatitis B Surface Antigen Mutants". Emerging Infectious Diseases. 12 (2): 198-203. ... Breakthrough cases of Hepatitis B are primarily attributed to mutations in the Hepatitis B virus (HBV) that make HBV surface ... Breakthrough infections of Hepatitis B and mumps are partially attributed to antigenic drift. Vaccines may fail to provide ... If B cell receptors bind to the antigen and FC receptors simultaneously bind to the maternal antibody, the FC receptors send a ...
Hepatitis B: certain antigens present during hepatitis can accumulate in the kidneys and damage them. ... Liver failure caused by cirrhosis, hepatitis and other conditions such as alcoholism, IV drug use or some hereditary diseases ... HIV: the virus's antigens provoke an obstruction in the glomerular capillary's lumen that alters normal kidney function. ...
December 1993). "Human leukocyte antigen A1-B8-DR3-DQ2-DPB1*0401 extended haplotype in autoimmune hepatitis". Hepatology. 18 (6 ... In autoimmune hepatitis[edit]. In 1972, a link between "HLA A1,8" (current:HLA A1-B8) active chronic hepatitis, subsequently B8 ... human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors". Hepatology. 13 (4): 701-6. doi:10.1002/hep.1840130415 ... "Genetic association of autoimmune hepatitis and human leucocyte antigen in German patients". World J. Gastroenterol. 12 (34): ...
In 1964, while studying "yellow jaundice" (hepatitis), he discovered a surface antigen for hepatitis B in the blood of an ... 3. The age of antigens and electronic microscopy" [History of hepatitis. 3. The age of antigens and electronic microscopy]. La ... a nonprofit organization dedicated to finding a cure for hepatitis B and improving the lives of those affected by hepatitis B ... Blumberg and his team were able to develop a screening test for the hepatitis B virus, to prevent its spread in blood donations ...
... has been found to have homology to hepatitis delta virus antigen (HDAg). DIPA interacts with the viral antigen, HDAg, and can ... Long M, de Souza SJ, Gilbert W (May 1997). "Delta-interacting protein A and the origin of hepatitis delta antigen". Science. ... Brazas R, Ganem D (Oct 1996). "A cellular homolog of hepatitis delta antigen: implications for viral replication and evolution ... Hepatitis delta virus (HDV) is a pathogenic human virus whose RNA genome and replication cycle resemble those of plant viroids ...
... (also known as the Australia antigen) is the surface antigen of the hepatitis B virus (HBV). It indicates current ... Today, these antigen-proteins can be genetically manufactured (e.g. transgene E. coli) to produce material for a simple antigen ... "Positive hepatitis B surface antigen tests due to recent vaccination: a persistent problem". BMC Clinical Pathology. 12 (1): 15 ... The viral envelope of an enveloped virus has different surface proteins from the rest of the virus which act as antigens. These ...
Alipour, Elias (23 June 2013). "Gold nanoparticle based capacitive immunosensor for detection of hepatitis B surface antigen". ... Hepatitis B Prepared AuNPs-Hepatitis B virus (HBV) DNA gene probes could be used to detect HBV DNA directly. The detection- ...
... (core antigen) is a hepatitis B viral protein. It is an indicator of active viral replication; this means the person ... May 2003). "New enzyme immunoassay for detection of hepatitis B virus core antigen (HBcAg) and relation between levels of HBcAg ... HBcAg is an antigen that can be found on the surface of the nucleocapsid core (the inner most layer of the hepatitis B virus). ... "In vivo inhibition of anti-hepatitis B virus core antigen (HBcAg) immunoglobulin G production by HBcAg-specific CD4(+) Th1-type ...
... they will bind to antigens within the HEp-2 cell nucleus. These antibodies can be visualised by subsequent incubation with anti ... Extractable nuclear antigens[edit]. Extractable nuclear antigens (ENA) are a group of autoantigens that were originally ... Typically, HEp-2 cells are used as a substrate to detect the antibodies in human serum. Microscope slides are coated with HEp-2 ... Comparison with autoimmune hepatitis and impact on the disease profile". Hepatology. 26 (3): 561-566. doi:10.1002/hep.510260305 ...
"Stimulation of RNA polymerase II elongation by hepatitis delta antigen". Science. 293 (5527): 124-7. doi:10.1126/science. ...
The coating, hepatitis B surface antigen (HBsAg), is not infectious; however, HBsAG can provoke an immune response. In order to ... Donald G. McNeil, Jr., April 26, 2012, Irving Millman Dies at 88; Worked to Stop Hepatitis B, The New York Times. His Hepatitis ... Millman's work with Baruch Blumberg helped lead to the creation of a test to detect hepatitis B. The test allowed blood banks ... Millman and Blumberg found that the blood of individuals who carried the hepatitis B virus contained particles of the outside ...
The appearance is classically associated with abundant hepatitis B antigen in the endoplasmic reticulum, but may also be drug- ... Hadziyannis, S; Gerber, MA; Vissoulis, C; Popper, H (Nov 1973). "Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes ... In the context of hepatitis B, GGHs are only seen in chronic infections, i.e. they are not seen in acute hepatitis B. GGHs were ... Drug reaction Mallory body Viral hepatitis Micrograph showing ground glass hepatocytes. H&E stain. Micrograph showing ground ...
Kumar GB, Ganapathi TR, Revathi CJ, Srinivas L, Bapat VA (October 2005). "Expression of hepatitis B surface antigen in ... Dendritic cell vaccines combine dendritic cells with antigens in order to present the antigens to the body's white blood cells ... such as the hepatitis B surface antigen). They can generate TH and antibody responses, but not killer T cell responses.[ ... This presents the antigen in such a way as to produce a greater action than the simple aqueous tetanus toxoid. People who have ...
"HLA antigens in Japanese patients with primary biliary cirrhosis and autoimmune hepatitis". Digestion. 26 (4): 213-7. doi: ... HLA-DR2 (DR2) of the HLA-DR serotype system, is a broad antigen serotype that is now preferentially covered by HLA-DR15 and HLA ... Tissue Antigens. 69 Suppl 1: 228-30. doi:10.1111/j.1399-0039.2006.77311.x. PMID 17445206. Asakura H, Tsuchiya M, Aiso S, ... primary biliary cirrhosis and autoimmune hepatitis. DR2 is also found in all patients that test positive for anti-anti-Asn-RNA- ...
Yap SF (June 2004). "Hepatitis B: review of development from the discovery of the "Australia Antigen" to end of the twentieth ... Bihl F, Negro F (May 2010). "Hepatitis E virus: a zoonosis adapting to humans". The Journal of Antimicrobial Chemotherapy. 65 ( ... In 1963, the hepatitis B virus was discovered by Baruch Blumberg (b. 1925).[67] Reverse transcriptase, the key enzyme that ... Zetterström R (March 2008). "Nobel Prize to Baruch Blumberg for the discovery of the aetiology of hepatitis B". Acta ...
Hepatitis Weekley, Autoimmune Diseases, "Cytotoxic Antigen Induces Hypophysitis in Cancer Patients," 2006-1-9; see also, Weston ... "Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic ...
"Fibronectin and asialoglyprotein receptor mediate hepatitis B surface antigen binding to the cell surface". Arch. Virol. 155 (6 ... The asialoglycoprotein receptor may facilitate hepatic infection by multiple viruses including hepatitis B, and is also a ... "Asialoglycoprotein receptor interacts with the preS1 domain of hepatitis B virus in vivo and in vitro". Arch. Virol. 156 (4): ...
"Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis". Lancet. 355 (9214): 1510-5. doi:10.1016/ ... "Entrez Gene: SLA/LP soluble liver antigen/liver pancreas antigen". Herkel J, Heidrich B, Nieraad N, Wies I, Rother M, Lohse AW ... Volkmann M, Martin L, Bäurle A, Heid H, Strassburg CP, Trautwein C, Fiehn W, Manns MP (2001). "Soluble liver antigen: isolation ... SECp43 and soluble liver antigen, in the selenoprotein synthesis machinery". J. Biol. Chem. 280 (50): 41568-75. doi:10.1074/jbc ...
"Hepatitis B small surface antigen particles are octahedral". Proceedings of the National Academy of Sciences of the United ... Cited in PMC Wieland, S. F.; Chisari, F. V. (2005). "Stealth and cunning: Hepatitis B and hepatitis C viruses". Journal of ... they produced a transgenic mouse model that overexpressed the large envelope protein of the hepatitis B surface antigen (HBsAg ... known for his research on virus-host interactions of hepatitis B and hepatitis C. Chisari graduated in 1963 with a bachelor's ...
4 December 2007). "Treatment of hepatitis B e antigen positive chronic hepatitis with telbivudine or adefovir: a randomized ... and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B". Gastroenterology. 129 (2): 528-36. ... Telbivudine impairs hepatitis B virus (HBV) DNA replication by leading to chain termination. It differs from the natural ... Telbivudine is an antiviral drug used in the treatment of hepatitis B infection. It is marketed by Swiss pharmaceutical company ...
West, D. J.; Calandra, G. B. (1996). "Vaccine induced immunologic memory for hepatitis B surface antigen: implications for ...
Hraber P, Kuiken C, Yusim K (December 2007). "Evidence for human leukocyte antigen heterozygote advantage against hepatitis C ... doi:10.1002/hep.21889. PMID 17935228. Rikowski A, Grammer K (May 1999). "Human body odour, symmetry and attractiveness". Proc. ...
2011). "Evaluation of saliva specimens as an alternative sampling method to detect hepatitis B surface antigen". J. Clin. Lab. ... Hepatitis C has also been identified using salivary detection methods. Yaari, et al., reported in 2006 that saliva testing for ... Amado LA, Villar LM, de Paula VS, Gaspar AM (March 2008). "Comparison between serum and saliva for the detection of hepatitis A ... A 2011 study demonstrated that HBV surface antigen saliva testing using ELISA had a sensitivity and specificity of 93.6% and ...
Hraber P, Kuiken C, Yusim K (December 2007). "Evidence for human leukocyte antigen heterozygote advantage against hepatitis C ... doi:10.1002/hep.21889. PMID 17935228.. *^ Rikowski A, Grammer K (May 1999). "Human body odour, symmetry and attractiveness". ... Resistance to hepatitis C virus infectionEdit. There is evidence that genetic heterozygosity in humans provides increased ...
Blumberg BS, Sutnick AI, London WT, Millman I (1970). "Australia antigen and hepatitis". The New England Journal of Medicine. ... There are numerous causes, including viruses - particularly hepatitis A virus, hepatitis B virus and hepatitis C virus. ... Hepatitis A virus was discovered in 1974. The discovery of hepatitis B virus and the invention of tests to detect it have ... In the 1960s, the first virus that could cause hepatitis was discovered. This was hepatitis B virus, which was named after the ...
Kumar GB, Ganapathi TR, Revathi CJ, Srinivas L, Bapat VA (October 2005). "Expression of hepatitis B surface antigen in ... Dendritic cell vaccines combine dendritic cells with antigens in order to present the antigens to the body's white blood cells ... hepatitis A, hepatitis B, polio, mumps, measles, rubella, diphtheria, pertussis, tetanus, HiB, chickenpox, rotavirus, influenza ... This presents the antigen in such a way as to produce a greater action than the simple aqueous tetanus toxoid. People who have ...
Hepatitis B Virus-Specific CD8+ T Cells Maintain Functional Exhaustion after Antigen Reexposure in an Acute Activation Immune ... MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution. Proceedings of the National ... An induced rebinding model of antigen discrimination. Trends Immunol. 2014, 35 (4): 153-8. PMC 3989030. PMID 24636916. doi: ...
"Characterization of RNA-binding domains of hepatitis delta antigen". J. Gen. Virol. 74 (Pt 11): 2473-2478. PMID 8245865.. CS1 ... hepatitis G. Viri[uredi , uredi kodo]. *↑, Slovenski medicinski e- ... Taylor JM (2006). "Hepatitis delta virus". Virology. 344 (1): 71-76. doi:10.1016/j.virol.2005.09.033. PMID 16364738.. ... Hepatitis D je oblika hepatitisa, ki ga povzroča virus hepatitisa D (VHD); le-ta za svoj razvoj potrebuje virus hepatitisa B. ...
"First Antigen Rapid Test for Ebola through Emergency Assessment and Eligible for Procurement". World Health Organization (WHO ... and viral hepatitis among others.[104] ... a rapid antigen test which gives results in 15 minutes was ...
"Chronic Hepatitis After Hepatitis E Virus Infection in a Patient With Non-Hodgkin Lymphoma Taking Rituximab" (PDF). Retrieved ... It increases MHC II and adhesion molecules LFA-1 and LFA-3 (lymphocyte function-associated antigen). ... Rituximab has been reported as a possible cofactor in a chronic Hepatitis E infection in a person with lymphoma. Hepatitis E ... Other severe side effects include reactivation of hepatitis B in those previously infected, progressive multifocal ...
"Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus". J. Infect. Dis. 201 (9): 1371-80. doi ... "Expression of apolipoprotein C-IV is regulated by Ku antigen/peroxisome proliferator-activated receptor gamma complex and ...
... has been reported as a possible cofactor in a chronic Hepatitis E infection in a person with lymphoma. Hepatitis E ... It increases MHC II and adhesion molecules LFA-1 and LFA-3 (lymphocyte function-associated antigen). ... Other severe side effects include reactivation of hepatitis B in those previously infected, progressive multifocal ...
However, immunofluorescence essays provide less definitive proof of Lassa infection.[7] An ELISA test for antigen and ... ELISA antigen assays, plaque neutralization assays, and immunofluorescence essays. ...
Liver biopsy can verify inflammation and necrosis of hepatocytes and detect viral antigens. Because of the bleeding tendency of ... Mitchell misdiagnosed the disease that he observed and treated, and the disease was probably Weil's disease or hepatitis. See: ... ribavirin in reducing liver pathology in yellow fever virus infection may be similar to its activity in treatment of hepatitis ...
The immune complexes are formed by binding of antibodies to antigens in the glomerular basement membrane. The antigens may be ... Within membranous glomerulonephritis, especially in cases caused by viral hepatitis, serum C3 levels are low.[7] ... Other studies have implicated neutral endopeptidase and cationic bovine serum albumin as antigens.[4] ... "M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy". The New England Journal of Medicine ...
Hepatitis. DNA virus. HBV (B). RNA virus. CBV. HAV (A). HCV (C). HDV (D). HEV (E). HGV (G). ... A map of the genome of JC virus, indicating the position of the tumor antigen genes (red), the three capsid protein genes ( ... Further research is needed to determine the exact etiological role of T-antigen, but there seems to be a connection to the ... T-antigen, also plays a key role in viral proliferation,[11] directing the initiation of DNA replication for the virus as well ...
... is to conjugate the antigens. Conjugation is the attachment to the antigen of another substance which also generates an immune ... A more contemporary approach for "boosting" the immune response to simpler immunogenic molecules (known as antigens) ... In the future it might be possible to artificially design antibodies to fit specific antigens, then produce them in large ... response, thus amplifying the overall response and causing a more robust immune memory to the antigen. For example, a toxoid ...
... antigen - antigen presentation - antigen-presenting cell (APC) - antineoplastic - antiprotozoal - antiretroviral drugs - ... hepatitis - hepatitis C and HIV coinfection - hepatomegaly - herpes simplex virus 1 (HSV-1) - herpes simplex virus 2 (HSV-2) - ... human leukocyte antigens (HLA) - human papilloma virus (HPV) - human T cell lymphotropic virus type I (HTLV-I) - human T cell ...
These cells bind antigens presented on MHC I complex of virus-infected or tumour cells and kill them. Nearly all nucleated ... Infectious diseases - viral (AIDS, SARS, West Nile encephalitis, hepatitis, herpes, measles, others), bacterial (TB, typhoid, ... Basophils are chiefly responsible for allergic and antigen response by releasing the chemical histamine causing the dilation of ... Dendritic cells (Although these will often migrate to local lymph nodes upon ingesting antigens) ...
Family Nackednaviridae - e.g. African cichlid nackednavirus (ACNDV), formerly named African cichlid hepatitis B virus (ACHBV).[ ... Group-specific antigen (gag) proteins are major components of the viral capsid, which are about 2000-4000 copies per virion. ... "Deciphering the Origin and Evolution of Hepatitis B Viruses by Means of a Family of Non-enveloped Fish Viruses". Cell Host & ...
In 1985, the first human vaccine obtained by genetic engineering from animal cells, the vaccine against hepatitis B, was ... as an antigen, Richard F. J. Pfeiffer introduced it in the abdomen of a guinea pig already vaccinated against this disease, and ... and hepatitis B. The discovery and use of sulfonamides in treating infections was another breakthrough. Some researchers won ... and they deduced that it can play the role of antigen, that is if they could overcome the delicate moment of its injection, ...
... whether in the form of viral hepatitis (e.g. hepatitis B or hepatitis C),[22][23][24] alcoholic liver disease, or cirrhosis of ... Serum levels of carcinoembryonic antigen (CEA) and CA19-9 are often elevated, but are not sensitive or specific enough to be ... hepatitis C, hepatitis B, infection with certain liver fluke, and some congenital liver malformations.[1][3][8] However, most ... doi:10.1002/hep.20537. PMID 15690474.. *^ Holzinger F, Z'graggen K, Büchler MW (1999). "Mechanisms of biliary carcinogenesis: a ...
"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome". Science 244 (4902): 359-62. April ... Detection by Immune Electron Microscopy of a Viruslike Antigen Associated with Acute Illness". Science 182 (4116): 1026-1028. ... Feinstone, Stephen M.; Kapikian, Albert Z.; Purcell, Robert H. (1973). "Hepatitis A: ...
The alpha-3 subunit (COL4A3) of collagen IV is thought to be the antigen implicated in Goodpasture syndrome, wherein the immune ... "Serum Collagen Type IV for the Assessment of Fibrosis and Resistance to Interferon Therapy in Chronic Hepatitis C". ... IV concentrations correlate with hepatic tissue levels of collagen IV in subjects with alcoholic liver disease and hepatitis C ...
The tests are based upon the ability of an antibody to bind specifically to an antigen. The antigen (usually a protein or ... "Hepatitis C". World Health Organization. Archived from the original on 2011-07-12. Retrieved 2013-04-25.. ... Using a similar basis as described above, immunoassays can detect or measure antigens from either infectious agents or the ... This technique is the current standard for detecting viral infections such as AIDS and hepatitis. ...
Usually, a target cell line expressing a certain surface-exposed antigen is incubated with antibody specific for that antigen. ... whose membrane-surface antigens have been bound by specific antibodies.[1] It is one of the mechanisms through which antibodies ...
Alter co-discovered the Australia antigen, a key to detecting hepatitis B virus. For many investigators that would be the ... Alter and his research team demonstrated that most post-transfusion hepatitis cases were not due to hepatitis A and hepatitis B ... Alter and his research team demonstrated that most post-transfusion hepatitis cases were not due to hepatitis A and hepatitis B ... This work eventually led to the discovery of the hepatitis C virus. In 1988 the new hepatitis virus was confirmed by Alter's ...
1 - antigen. 2 - IgE antibody. 3 - FcεRI receptor. 4 - preformed mediators (histamine, proteases, chemokines, heparin). 5 - ... Other widely promoted tests such as the antigen leukocyte cellular antibody test and the food allergy profile are considered ...
Schwann cell antigen. Neuritis, paralysis. Hashimoto's thyroiditis[1]. Thyroglobulin antigen. Hypothyroidism, hard goiter, ... Target antigen. Effects. Allergic contact dermatitis[1]. Environmental chemicals, like urushiol (from poison ivy and poison oak ... Myelin antigens (e.g., myelin basic protein). Myelin destruction, inflammation. Rheumatoid arthritis[1]. Possibly collagen and/ ... CD4+ Th1 helper T cells recognize antigen in a complex with the MHC class II major histocompatibility complex on the surface of ...
... has a 10-40-fold preference for hemimethylated DNA and interacts with the proliferating cell nuclear antigen (PCNA).[51] ... The Human Epigenome Project (HEP). *The Epigenome Network of Excellence (NoE). *Canadian Epigenetics, Environment and Health ...
For development of a system to study the replication of the virus that causes hepatitis C and for use of this system to ... cells-the preeminent component of the immune system that initiates and regulates the body's response to foreign antigens.[34] ... Discovery of the virus that causes hepatitis C and the development of screening methods that reduced the risk of blood ... transfusion-associated hepatitis in the U.S. from 30% in 1970 to virtually zero in 2000.[56] ...
... the first known hepatitis with a viral etiological agent was Hepatitis A, in the picornaviridae family. Hepatis B Virus (HBV) ... surface antigens-preS1, preS2, and S, the X protein and HBeAg. The X protein is thought to be non-structural. Its function and ... Endogenous hepatitis B virus genomes have been described in crocodilian, snake and turtle genomes.[7] This suggests that these ... Hepatitis viruses have been described in fish and amphibians also.[4] This suggests that this family has co evolved with the ...
It has been suggested that absorption of trichophyton fungal antigens can give rise to immunoglobulin E (IgE) antibody ... Hepatitis C, or HIV. Davies et al. surveyed podiatrists and found that 41% of them complained of eye problems, particularly ... of the population has allergic antibodies to fungal antigens, and half of them, that is 5% of the population, would be ... of podiatry drill burrs potentially expose the healthcare worker to aerosols containing bloodborne pathogens such as Hepatitis ...
Blood is usually collected and tested for common or serious Blood-borne diseases including Hepatitis B, Hepatitis C and HIV. ... Approximately 25 of these membrane proteins carry the various blood group antigens, such as the A, B and Rh antigens, among ... Blood Groups and Red Cell Antigens *^ a b Pierigè F, Serafini S, Rossi L, Magnani M (January 2008). "Cell-based drug delivery ... Kidd antigen protein - urea transporter;. *RhAG - gas transporter, probably of carbon dioxide, defines Rh Blood Group and the ...
Immureboost presented a product at the Therapies for Viral Hepatitis Symposium to Boston Scientists. The ... In this sense V1 is similar to the first generation of commercial Hepatitis B vaccine, which contained pooled viral antigens ... Separately, three patients who were Hepatitis B antigen positive became negative after V1 therapy. In contrast, patients who ... Hepatitis is a serious and potentially life-threatening disease which may culminate in liver cancer. Hepatitis B causes 60% to ...
Hepatitis core antigen (IPR002006). Short name: Hepatitis_core Overlapping homologous superfamilies *Viral capsid core domain ... This entry represent the core antigen of the viral capsid (HBcAg) from various Hepatitis B virus (HBV), which is a major human ... The capsid is composed of a single polypeptide, HBcAg, also known as the core antigen. The capsid has a 5-helical fold, where ... This viral capsid acts as a core antigen, the major immunodominant region lying at the tips of the alpha-helical hairpins that ...
Hepatitis-associated antigen in chronic hepatitis. Br Med J 1973; 3 :49 ... Hepatitis-associated antigen in chronic hepatitis.. Br Med J 1973; 3 doi: (Published 07 ...
Reactive Hepatitis B Surface Antigen will reflex to the Hepatitis B Surface Antigen Confirmatory neutralization test for an ... Home : For health professionals : Refer a patient : Laboratory Services : Test Table : HEPATITIS B SURFACE ANTIGEN ...
Definition of hepatitis B e antigen. Provided by Stedmans medical dictionary and Includes medical terms and ... hepatitis B e antigen. Definition: an antigen, or group of antigens, associated with hepatitis B infection and distinct from ... the surface antigen (HBsAg) and the core antigen (HBcAg); it is associated with the viral nucleocapsid. Its presence indicates ...
HbS antigen. positive. hep e antigen.Negative.HBV DNA.Negative.I am on treatment with lumividine tab 100 mg/day for about 3 yrs ... I am diagnosed as Hep B carrier.My test reports: ... Hep B surface antigen positive. I am diagnosed as Hep B carrier ... I am diagnosed as Hep B carrier.My test reports:HbS antigen. positive. hep e antigen.Negative.HBV DNA.Negative.I am on ... hep e antigen.Negative.HBV DNA.Negative.I am on treatment with lumividine tab 100 mg/day for about 3 yrs.My ALT level & liver ...
... gene of hepatitis B surface antigen (HBsAg) using Agrobacteriummediated transformation. Four different expression... ... Agrobacterium Edible vaccine Embryogenic cells Hepatitis B surface antigen Transgenic banana Abbreviations. ADS. Adenine ... Mason HS, Lam DMK, Arntzen CJ (1992) Expression of hepatitis B surface antigen in transgenic plants. Proc Nat Acad Sci USA 89: ... Rasthali (AAB) have been transformed with the s gene of hepatitis B surface antigen (HBsAg) using Agrobacterium mediated ...
Identification and Management of Hepatitis B Surface Antigen (HBsAg)--Positive Persons. Persons with chronic hepatitis B virus ... obtain vaccination against hepatitis A if chronic liver disease is present (2). *When seeking medical or dental care, HBsAg- ... Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization ... Hepatitis B virus transmission between children in day care. Pediatr Infect Dis J 1989;8:870--5. ...
2013 Sep;58(3):881-9. doi: 10.1002/hep.26415. Epub 2013 Jul 29. Multicenter Study; Research Support, N.I.H., Extramural; ... Synergism of tapasin and human leukocyte antigens in resolving hepatitis C virus infection.. Ashraf S1, Nitschke K, Warshow UM ... Human leukocyte antigen (HLA) class I presents viral peptides to CD8+ T cells to permit detection of infected cells, and ... CD8+ T-cell responses to hepatitis C virus (HCV) are important in generating a successful immune response and spontaneously ...
Hepatitis b surface antigen definition at, a free online dictionary with pronunciation, synonyms and translation ... hepatitis b surface antigen in Medicine Expand. hepatitis B surface antigen n. Abbr. HBsAg An antigen of the small spherical ... and filamentous forms of hepatitis B antibodies that is also present on the Dane particle. ... Nearby words for hepatitis b surface antigen. * hepatitis a * hepatitis a virus ...
Hepatitis b e antigen definition at, a free online dictionary with pronunciation, synonyms and translation. Look ... hepatitis b e antigen in Medicine Expand. hepatitis B e antigen n. Abbr. HBe, HBeAg A core protein antigen of the hepatitis B ...
Hepatitis B virus-specific (HBV-specific) T cells have been identified as main effector cells in HBV clearance. In contrast, B ... cells producing neutralizing antibodies against the HBV surface antigen (HBsAg) have been studied in little detail, mainly due ...
Western and dot immunoblotting analysis of viral antigens and antibodies: application to murine hepatitis virus.. Talbot PJ, ...
What is viral hepatitis antigens? Meaning of viral hepatitis antigens medical term. What does viral hepatitis antigens mean? ... Looking for online definition of viral hepatitis antigens in the Medical Dictionary? viral hepatitis antigens explanation free ... viral hepatitis antigens. vi·ral hep·a·ti·tis an·ti·gens (vīrăl hepă-tītis anti-jĕnz) Immunogenic components of hepatitis ... Viral hepatitis antigens , definition of viral hepatitis antigens by Medical dictionary https://medical-dictionary. ...
Buy our Recombinant Hepatitis A Virus Surface Antigen protein. Ab68870 is an active protein fragment produced in Escherichia ... Recombinant Hepatitis A Virus Surface Antigen protein. See all Hepatitis A Virus Surface Antigen proteins and peptides. ... Hepatitis A virus (HAV), the causative agent of type A viral hepatitis, is spread by faecal-oral contact or ingestion of ... Microbiology Organism Virus RNA Virus ssRNA positive strand virus Hepatitis A/C/E/G ...
Buy our Recombinant Hepatitis B Virus E Antigen protein. Ab91273 is an active full length protein produced in Escherichia coli ... Hepatitis B e-antigen (HBeAg) is a viral protein associated with HBV infections. Unlike the surface antigen, the e-antigen is ... When the virus goes into "hiding," the e-antigen will no longer be present in the blood. HBeAg is often used as a marker of ... of HBV that do not make e-antigen; these are especially common in the Middle East and Asia. In areas where these strains of HBV ...
B news Hepatitis B Outreach hepatitis B vaccine hepatitis C hepatitis D hepatocellular carcinoma HepB hep B Hep B Awareness Hep ... Hepatitis B Diagnosis & Monitoring, Hepatitis B Prevention, Living with Hepatitis B Youve Lost the Hepatitis B Surface Antigen ... Tag Archives: hepatitis B surface antigen. Hepatitis B Diagnosis & Monitoring, Hepatitis B Treatment ... discrimination HBV vaccine HCC HCV HDV hepatitis B Hepatitis B Hepatitis B Foundation Hepatitis B Foundation Events Hepatitis ...
PREVALENCE OF HEPATITIS B SURFACE ANTIGEN. The rate of positive results for hepatitis B surface antigen was 0.7% in our ... All blood samples positive for hepatitis B surface antigen were also tested for hepatitis B e antigen and its antibody (Abbott ... Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in ... Of the 705 women positive for hepatitis B surface antigen, 118 (16.7%) were positive for the e antigen. The rate of positive ...
Most patients do not turn their surface antigen to negative on treatment. The next best results we hope... ... The length of treatment will depend on your type of hepatitis B infection - e antigen negative or e antigen positive. Discuss ... Ask the Experts > Forum on Hepatitis and HIV Coinfection > Q & A Antigen positive to Non-reactive. Sep 25, 2005 How long is the ... Most patients do not turn their surface antigen to negative on treatment. The next best results we hope for is to turn the ...
... then the surface antigen can mean a chronic carrier state that is inactive due to no virus in her blood. Yes I would agree that ... If your wife is at risk for hepatitis B, ... hep B Surface Antigen Positive. Feb 4, 2006 My wife recently ... If your wife is at risk for hepatitis B, then the surface antigen can mean a chronic carrier state that is inactive due to no ... Yes I would agree that she should see a specialist to be certain that: 1. The hepatitis B surface antigen was confirmed. 2. To ...
"Australia antigen", later renamed HBsAg (for hepatitis B surface antigen), in patient blood [6]. HBeAg (hepatitis B e antigen) ... Milich D, Liang J. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology. 2003 ;38 ... Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus. J. Virol. 1989 ;63:798-808 ... Mutation preventing formation of the hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet. 1989 ;2:588- ...
This invention relates to a DNA fragment comprising a base sequence encoding a non-A non-B hepatitis-specific antigen ... Non-A non-B hepatitis specific antigen and its use in hepatitis ... hepatitis B, hepatitis D and other hepatitis symptoms caused by ... with serum from a normal person or non-A non-B hepatitis patient, wherein the antigens used are a purified antigen in A, an ... 1. An isolated DNA fragment coding for a non-A non-B hepatitis-specific antigen polyopeptide, said DNA fragment having a ...
Browse our Hepatitis C Virus Core Antigen all backed by our Guarantee+. ... Hepatitis C Virus Core Antigen available through Novus Biologicals. ...
Browse our Hepatitis A Surface Antigen Antibody catalog backed by our Guarantee+. ... Hepatitis A Surface Antigen Antibodies available through Novus Biologicals. ... Hepatitis A Surface Antigen Antibodies. We offer Hepatitis A Surface Antigen Antibodies for use in common research applications ... Choose from our Hepatitis A Surface Antigen monoclonal antibodies.. Alternate Names for Hepatitis A Surface Antigen Antibodies ...
LBDHBG - Hepatitis B surface antigen. Variable Name: LBDHBG SAS Label: Hepatitis B surface antigen. English Text: Hepatitis B ... LBDHD - Hepatitis D (anti-HDV). Variable Name: LBDHD SAS Label: Hepatitis D (anti-HDV). English Text: Hepatitis D (anti-HDV). ... Hepatitis B: Core Antibody, Surface Antigen; Hepatitis D Antibody (HEPBD_G) Data File: HEPBD_G.xpt First Published: September ... The Hepatitis B surface antigen is tested only when the Hepatitis B core antibody test is positive. Participant results are ...
LBDHBG - Hepatitis B surface antigen. Variable Name: LBDHBG. SAS Label: Hepatitis B surface antigen. English Text: Hepatitis B ... Hepatitis B: Core Antibody, Surface Antigen; Hepatitis D Antibody (HEPBD_D) Data File: HEPBD_D.xpt First Published: February ... LBDHD - Hepatitis D (anti-HDV). Variable Name: LBDHD. SAS Label: Hepatitis D (anti-HDV). English Text: Hepatitis D (anti-HDV). ... LBXHBC - Hepatitis B core antibody. Variable Name: LBXHBC. SAS Label: Hepatitis B core antibody. English Text: Hepatitis B core ...
Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria  Egah, D.Z.; Banwat, E.B. ... Prevalence of hepatitis B surface antigen and hepatitis C virus antibodies among blood donors in Alexandria, Egypt  Wasfi, O.A ... Serum level of anti-hepatitis B surface antigen 6-8 years after hepatitis B vaccination at birth  Kazemi, A.; Koosha, A.; ... were tested for hepatitis B surface antigen [‎HBsAg]‎ and anti-hepatitis C virus [‎HCV]‎ antibodies. A total of 119 donors [‎ ...
History of Hepatitis B; Detection of antigen in serum of acute hepatitis; Comments on delta agent of the antigen. ... Association of the discovery of the Australia antigen or hepatitis-associated antigen with... ... Hepatitis-Associated Antigen and Viruses. London, W. Thomas // Annals of Internal Medicine;Apr73, Vol. 78 Issue 4, p624 Reviews ... Familial hepatoma with hepatitis-associated antigen. Denison, Edward K.; Peters, Robert L.; Reynolds, Telfer B.; Denison, E K; ...
Different guidelines exist for the management of hepatitis B virus (HBV)-infected healthcare workers (HCWs). Various HBV DNA ... Different guidelines exist for the management of hepatitis B virus (HBV)-infected healthcare workers (HCWs). Various HBV DNA ... Hepatitis B e antigen-positive Healthcare Workers More in this Section.... Infection Prevention and Safety Issue TOOLKITS. ...
Hepatitis B Virus Core Antigen Antibody (13A9), MA1-7606, from Invitrogen™. Species Reactivity: Virus; Applications: ELISA, ... The antigens in the outer surface are called as hepatitis B virus surface antigens. Core antigens are localized within the ... Antibodies to surface antigens appear in circulation at an early stage of infection whereas the antibodies to the core antigens ... The antigenic activity of the nucleocapsid core is designated as hepatitis B core antigen. ...
  • Rasthali (AAB) have been transformed with the ' s ' gene of hepatitis B surface antigen (HBsAg) using Agrobacterium mediated transformation. (
  • In contrast, B cells producing neutralizing antibodies against the HBV surface antigen (HBsAg) have been studied in little detail, mainly due to methodical limitations. (
  • HBsAg, the protein that makes up the surface of the virus, is what labs look for in a blood sample to determine if a person is currently infected with hepatitis B. (
  • The strange thing about HBsAg, is that each hepatitis B virus requires only about 100 HBsAg molecules to provide its envelope protein, but the virus produces about 100- to 1 million-times more HBsAg than is needed, leaving millions of HBsAg circulating in the bloodstream," explained Timothy Block, president of the Hepatitis B Foundation and the Baruch S. Blumberg Institute, the foundation's research arm. (
  • Bottom line: A low or undetectable HBsAg level means patients are winning the war against hepatitis B and their risk of liver damage is greatly reduced. (
  • According to Quest Diagnostics, which created the test, measuring HBsAg levels better identifies which patients are at risk of hepatitis B reactivation. (
  • The virus was first discovered as "Australia antigen", later renamed HBsAg (for hepatitis B surface antigen), in patient blood [ 6 ]. (
  • Hepatitis B patients also contain circulating antibodies against HBcAg (hepatitis B core antigen), and will develop antibodies against HBeAg and HBsAg (anti-HBe and anti-HBs) at later stages of infection. (
  • We determined the serum level of antibody to hepatitis B surface antigen [‎anti-HBsAg]‎ in 273 randomly selected 7-9-year-old schoolchildren from Zanjan City, Islamic Republic of Iran, who had been fully vaccinated against hepatitis B starting at birth. (
  • The 55 codons upstream of the gene sequence encoding the hepatitis B surface antigen (HBsAg) are called the pre-S(2) region. (
  • Hepatitis D virus (HDV) is an incomplete RNA virus that needs hepatitis B surface antigen (HBsAg) to help its replication. (
  • To estimate the prevalence of hepatitis D virus infection among HBsAg positive individuals. (
  • Changes of HBsAg and HBV DNA levels in Chinese chronic hepatitis B patients after 5 years of entecavir treatment. (
  • Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B. (
  • Mutations that occur within the immunodominant epitopes of hepatitis B surface antigen (HBsAg) allow mutant virus to propagate in the presence of a neutralizing immune response, while wild-type virus is reduced to undetectable levels. (
  • An understanding of immunoassay reactivity with HBsAg mutants is key to establishing an appropriate testing algorithm for hepatitis B virus detection programs. (
  • This article addresses recent information concerning the emergence of hepatitis B surface antigen (HBsAg) mutants, their impact on viral antigen presentation, latest prevalence data, and discussion of the issues associated with detection of mutants in healthcare settings. (
  • Treatment with a combination of tenofovir and pegylated interferon yielded higher rates of hepatitis B surface antigen (HBsAg) loss than when either drug was used singly. (
  • A documented past history of hepatitis, living in 'asocial' wards in which at least one HBsAg carrier was present, long institutionalization (is greater than 10 yrs.), admission to the institution between ages 5 and 19, a present age between 20 and 39, and being male were associated with the presence of anti-HBs. (
  • 112 (34%) were females, 258 (79%) were injecting drug users (IDU), 25 (8%) were men who have sex with men (MSM), and 20 (6%) were hepatitis B surface antigen (HBsAg)-positive. (
  • The occurrence of the delta (delta) agent was analyzed in 89 patients with acute hepatitis B infection during 1976-1979 in Gothenburg, Sweden, and in 46 patients (16 drug addicts) with chronic HBsAg-positive liver disease. (
  • HBsAg is the surface antigenof the Hepatitis-B-Virus (HBV). (
  • HBsAg is a serological marker produced on the surface of the hepatitis B virus and is one of the first disease state markers to be detected in the serum of patients infected with the hepatitis B virus. (
  • Pregnant women are screened for a different antigen, the hepatitis B surface antigen (HBsAg) that also show an active infection with hepatitis B. If that test is positive, the HBeAg test may be done, along with tests such as the HBV DNA concentration and alanine aminotransferase (ALT) test for liver health. (
  • In hepatitis B, it's common to test for the hepatitis B surface antigen (HBsAg) and hepatitis B core antigen (HBcAg). (
  • This guidance provides recommendations for a requalification method or process for the reentry of deferred donors who test repeatedly reactive for hepatitis B surface antigen (HBsAg), confirmed positive by neutralization, following a recent vaccination against hepatitis B virus (HBV) infection, and who are not infected by HBV. (
  • To explore the predictive value of serum hepatitis B surface antigen (HBsAg) titer and transient elastography in screening for insignificant fibrosis in hepatitis B e antigen (HBeAg)-positive chronic hepatitis B patients. (
  • We assessed the serum HBsAg level, serum hepatitis B virus (HBV) deoxyribonucleic acid (DNA) level, HBV genotypes, liver stiffness measurement (LSM) values by transient elastography, and histological fibrosis staging by METAVIR classification. (
  • Hepatitis B virus surface antigen (HBsAg) is an important risk factor for hepatocellular carcinoma (HCC) and is downregulated during hepatocarcinogenesis. (
  • An open-label randomized study was undertaken to compare a 2-dose regimen (Months 0 and 6) of hepatitis B surface antigen (HBsAg) vaccine formulated with a novel adjuvant (HBsAg/AS04) with a standard 3-dose regimen (Months 0, 1 and 6) of licensed recombinant HBsAg vaccine in terms of immunogenicity and reactogenicity when administered to healthy subjects aged between 15 and 40 y. (
  • Hepatitis B Virus Surface antigen (HBsAg) standard, for use in running standard curves in AlphaLISA assays. (
  • A total of 69 persons were investigated for assessment of cell-mediated and humoral immunity to hepatitis B surface antigen (HBsAg). (
  • Three groups, each consisting of 20 normal persons, 20HBsAg carriers, and 20 convalescent hepatitis B patients, were studied for HBsAg, anti-HBs, and leukocyte migration inhibition with purified HBsAg. (
  • Sequential sampling if an additional group of nine acute hepatitis B patients defined the cellular and humoral immune response to HBsAg. (
  • The antigen was eliminated rapidly by mounting of cell-mediated immune response detectable for a limited period, followed by antibody response in relatively few patients moore than 3 months after clearance of circulating HBsAg. (
  • Thirty-five cases with hepatitis B surface antigen (HBsAg) positivity known prior to initiation of TNF-α inhibitors were identified. (
  • While such reactivation may be due to a variety of reasons, clinicians prescribing TNF-α inhibitors to HBsAg-positive patients should consider prophylactic antiviral therapy and close monitoring for any clinical or serological evidence of hepatitis. (
  • The age-specific prevalence of hepatitis B surface antigen (HBsAg) and antibody was studied in a random sample of Gilbert and Ellice islanders over the age of 10 years living in Nauru. (
  • The original term for the Australian antigen, now called hepatitis B surface antigen (HBsAg). (
  • Percentage of HBsAg-positive subjects detected using the hepatitis sAg/eAg test versus the HBsAg standard provided by NIBSC. (
  • For comparing factors between AHB patients with viral persistence and those with self-limited infection, 212 AHB patients without human immunodeficiency virus (HIV) coinfection were observed in 38 liver centers until serum hepatitis B surface antigen (HBsAg) disappeared or a minimum of 6 months in cases where HBsAg persisted. (
  • Many cell types efficiently present an epitope of the hepatitis B surface Ag (HBsAg) to murine class I-restricted CTL following an in vitro pulse with native 22-nm HBsAg particles. (
  • We have analyzed the molecular bases of the persistence of hepatitis B virus (HBV) DNA in serum and peripheral blood mononuclear cells (PBMC) in the absence of detectable hepatitis B surface antigen (HBsAg) in hemodialysis patients and dialysis-unit staff members who had suffered acute hepatitis B that resolved previously. (
  • No serum HBsAg/hepatitis B surface antigen antibody (anti-HBs) immune complexes or mutations in the "a determinant of the S gene were found. (
  • HBsAg serum level (quantification) may be useful for managing hepatitis B virus (HBV) infection patients. (
  • The objective of this study was to estimate the correlation between HBsAg serum level and liver fibrosis severity with treatment naive chronic hepatitis B patients in Cote d'Ivoire. (
  • Conclusion: This study shows that there's a negative correlation between HBsAg serum level and liver fibrosis severity treatment naive with African chronic hepatitis B viral HBeAg-negative patients. (
  • The hepatitis virus consists of a core containing DNA ( HBV-DNA ) with an enzyme known as DNA polymerase that assists with viral replication and is surrounded by surface proteins ( HBsAg ). (
  • The surface proteins surrounding the viral core is known as the hepatitis B surface antigen ( HBsAg ). (
  • Home » Products » Health Beauty » Diagnosis Equipment » HBsAg Test Strip/Hepatitis B Surface Antigen Test In total 213268 number ofProductsinfo,Released today. (
  • This entry represent the core antigen of the viral capsid (HBcAg) from various Hepatitis B virus (HBV), which is a major human pathogen. (
  • The capsid is composed of a single polypeptide, HBcAg, also known as the core antigen. (
  • Molecular cloning and sequencing of the HBV genome led to the redefinition of the three HBV antigens as viral gene products endowed with specific functions in viral life cycle [for an in-depth review on the molecular biology of HBV, see ref. 13].The HBcAg and HBeAg are alternative translation products of the core gene, with HBeAg translation requiring an upstream precore region ATG codon (Fig. 2 ). (
  • This involves the reaction of anti-HBc in the sample with hepatitis B core antigen (HBcAg) coated wells. (
  • Several assays have been developed for the measurement of serum hepatitis B e antigen (HBeAg) or hepatitis B core antigen (HBcAg) concentrations ( 1 , 3 , 16 ). (
  • Since HBeAg and HBcAg share a 149-amino-acid sequence identity, they are collectively called hepatitis B core-related antigens (HBcrAg) ( 5 , 13 ). (
  • In this assay, the specimens were pretreated so that HBeAg and HBcAg were released from the patients' own anti-HBe and anti-HBc antibody-antigen complexes, respectively. (
  • Hepatitis B e-antigen (HBeAg) is a viral protein associated with HBV infections. (
  • successful treatment will usually eliminate HBeAg from the blood and lead to development of antibodies against e-antigen (anti-HBe). (
  • The core promoter mutants express less HBe antigen (HBeAg) through transcriptional down regulation, while precore mutants express truncated products. (
  • HBeAg (hepatitis B e antigen) was identified several years later as a marker for patients at high risk for transmission of the disease [ 20 ]. (
  • Hepatitis B e antigen positive (HBeAg-positive) children are at high risk of severe complications such as hepatocellular carcinoma and cirrhosis. (
  • By revisiting our previous screen of microRNA plasma levels in HBeAg-positive and HBeAg-negative children with chronic hepatitis B (CHB) and in healthy controls, candidate microRNAs with aberrant plasma expressions in HBeAg-positive children were identified. (
  • Risk of progressive liver disease primarily applies to hepatitis B e antigen positive (HBeAg-positive) children and seroclearance of HBeAg is a key event in the natural course of disease [ 5 ]. (
  • HBeAg stands for hepatitis B e-antigen . (
  • People with chronic hepatitis B can show seroconversion-the levels of HBeAg dropping until they're undetectable while levels of anti-HBe antibodies develop. (
  • Interestingly, there are strains of hepatitis B virus that don't produce HBeAg. (
  • They can have an active Hepatitis B infection without a positive HBeAg test . (
  • Liaw Y-F. HBeAg Seroconversion as an Important End Point in the Treatment of Chronic Hepatitis B. Hepatology International . (
  • The proliferative response of PBMC to hepatitis B virus (HBV) envelope, core, and e Ag was analyzed prospectively in 21 patients with acute self-limited HBV infection and compared with the response of patients with chronic HBV infection and different levels of HBV replication (i.e., hepatitis e Ag (HBeAg)- or anti-HBe-positive) and liver damage (i.e., chronic active hepatitis or chronic asymptomatic carriers). (
  • Percentage of HBeAg-positive subjects detected using the hepatitis sAg/eAg test versus the PEI HBeAg standard. (
  • The objectives of this review were to assess the effects of the sequential combination of glucocorticosteroids and interferon compared to interferon alone in the treatment of chronic hepatitis B. Glucocorticosteroid pretreatment was associated with a significantly higher frequency of loss of hepatitis B markers (HBeAg and HBV DNA), but had no significant effect on clinical outcomes. (
  • Mellerup MT, Krogsgaard K, Mathurin P, Gluud C, Poynard T. Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B. Cochrane Database of Systematic Reviews 2005, Issue 3. (
  • In this sense V1 is similar to the first generation of commercial Hepatitis B vaccine, which contained pooled viral antigens derived from the blood of hepatitis B carriers. (
  • Western and dot immunoblotting analysis of viral antigens and antibodies: application to murine hepatitis virus. (
  • This assay detected picogram quantities of viral antigens and antibodies. (
  • And B-cells, so they don't generate the antibodies needed to destroy the viral antigens that make up the virus. (
  • Two-step immunohistochemical staining showed the expression of viral antigens in situ. (
  • Trans Am Clin Climatol Assoc. 2019;130:104-118 Authors: Alter HJ Abstract The modern age of viral hepatitis began in the early 1960s with the serendipitous discovery of the Australia antigen, a protein that was later shown to represent the envelope of the hepatitis B virus leading to its designation as the hepatitis B surface antigen. (
  • Authors: Mak LY, Ko KL, To WP, Wong DK, Seto WK, Fung J, Yuen MF Abstract Serum hepatitis B core-related antigen (HBcrAg) was shown to predict the risk of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients undergoing treatment. (
  • Unvaccinated sex partners and household and needle-sharing contacts should be tested for susceptibility to HBV infection (see Appendix A, Prevaccination Serologic Testing for Susceptibility) and should receive the first dose of hepatitis B vaccine immediately after collection of blood for serologic testing. (
  • Since the availability of hepatitis B vaccine the prevention of perinatal transmission of hepatitis B virus has become feasible. (
  • Duration of Immunity After Hepatitis B Vaccination: Efficacy of Low-Dose Booster Vaccine. (
  • Studies health care workers three years after initial vaccination with hepatitis B vaccine to determine the prevalence of immunity indicated by levels of antibody to hepatitis B surface antigen. (
  • Decline of vaccine coverage for hepatitis B. (
  • A 2-dose regimen of a recombinant hepatitis B vaccine with the immune stimulant AS04 compared with the standard 3-dose regimen of Engerix-B in healthy young adults. (
  • In 1991, the World at least 6-8 years before with 3 doses of Health Organization (WHO) recommended hepatitis B vaccine starting at birth to that hepatitis B vaccination be included provide information on the effect of the in national immunization programmes in immunization strategy for hepatitis B and countries with a hepatitis B surface antigen the need for booster doses. (
  • This was the first marker for any hepatitis virus and became not only a diagnostic assay, but also a mandatory blood donor screening test and the basis for the first generation hepatitis B vaccine. (
  • Hepatitis B vaccine is effective in preventing infection with hepatitis B virus (HBV), but its duration of protection is unknown. (
  • Breakthrough cases of Hepatitis B are primarily attributed to mutations in the Hepatitis B virus (HBV) that make HBV surface proteins unrecognizable to antibodies produced from the HBV vaccine. (
  • A boost in antibody to hepatitis B surface antigen (anti-HBs) was defined as a fourfold rise in levels to ≥20 mIU/mL that was not accompanied by the presence of antibody to hepatitis B core antigen or attributable to interim vaccination. (
  • A core protein antigen of the hepatitis B virus distinct from both the surface and core antigens. (
  • Hepatitis delta virus (HDV) is known to express a protein termed the small delta antigen, a structural protein which is also essential for genome replication. (
  • The antigen is a protein that binds specifically on one of these surface proteins. (
  • This antigen is a protein from the hepatitis B virus that circulates in infected blood when the virus is actively replicating. (
  • An antigen is a protein that stimulates an immune system response, causing your body to produce antibodies to fight invaders. (
  • Three of the children had antibodies to hepatitis B core protein. (
  • Hepatitis delta antigen (HDAg) is a nuclear protein that is intimately involved in hepatitis delta virus (HDV) RNA replication. (
  • The viral genomic RNA (G-RNA) is first replicated into the full-length antigenomic RNA (AG-RNA) and is also transcribed into a 0.8-kb mRNA, which encodes the only HDV protein, hepatitis delta antigen (HDAg). (
  • Reduction of hepatitis B surface antigen levels and hepatitis B surface antigen seroclearance in chronic hepatitis B patients receiving 10 years of nucleoside analogue therapy. (
  • Entecavir Reduced Serum Hepatitis B Core-Related Antigen in Chronic Hepatitis B Patients with Hepatocellular Carcinoma. (
  • Hepatitis B Surface Antigen Serum Level Is Correlated with Fibrosis Severity in Treatment-Naïve, Chronic Hepatitis B Patients in Côte d'Ivoire (West Africa)? (
  • This paper describes six mother and infant pairs where the mother developed serum hepatitis during pregnancy. (
  • Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults. (
  • Association of the discovery of the Australia antigen or hepatitis-associated antigen with. (
  • The Immureboost Company presented poster 'Normalization of Elevated Liver Enzymes due to V-1 Immureboost Therapy' at the international symposium Therapies for Viral Hepatitis held in Boston on October 29-31, 2002. (
  • Hepatitis is a serious and potentially life-threatening disease which may culminate in liver cancer. (
  • Hepatitis B causes 60% to 80% of the world's primary liver cancer with over one million people dying annually. (
  • Diagnosis of virally induced chronic hepatitis is often made when a patient presents elevated liver enzyme levels known as alanine (ALT or SGPT) and aspartate (AST or SGOT) aminotransferases. (
  • hep e antigen.Negative.HBV DNA.Negative.I am on treatment with lumividine tab 100 mg/day for about 3 yrs.My ALT level & liver ultrasound test normal.I wish to go abroad for a job and there Hep.B Surface antigen is tested.If one is positive, it is a sure rejection.Can inj. (
  • Persons with chronic hepatitis B virus (HBV) infection are at high risk for chronic liver disease and are a major reservoir of HBV infection. (
  • The core promoter mutants have been associated with the development of fulminant hepatitis during acute infection and liver cancer during chronic infection. (
  • Investigation of SEN Virus Infection in Patients with Cryptogenic Acute Liver Failure, Hepatitis-Associated Aplastic Anemia, or Acute and Chronic Non--A--E Hepatitis. (
  • The hepatitis-associated liver injury in HIV-infected cases has been one of the important reasons for mortality and morbidity in. (
  • The article discusses the increasing threats of Hepatitis B Virus (HBV), which attacks the liver cells and leads to cirrhosis, liver failure and liver cancer. (
  • Exacerbation of chronic liver disease due to hepatitis B surface antigen after delta infection. (
  • The hepatitis B virus is an important cause of acute and chronic liver disease. (
  • In conclusion, serum HBcrAg levels correlated with HBV virological markers and reflected the chronic hepatitis B disease activity in the liver. (
  • Jörg Petersen, MD, PhD, Director of the Liver Institute at IFI Institute for Interdisciplinary Medicine, University of Hamburg, presented findings from an international multicenter study of chronic hepatitis B (CHB) patients during The Liver Meeting 2014 in Boston, MA. (
  • Antibodies to hepatitis C virus, hepatitis B serology and liver enzymes were examined in 137 Finnish haemophiliac patients to detect signs of chronic viral hepatitis and its possible aetiological associations. (
  • Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation. (
  • Chronic hepatitis C is a serious liver disease that often results in cirrhosis or hepatocellular carcinoma. (
  • N-glycopeptide signatures of IgA2 in serum from patients with hepatitis B virus-related liver diseases. (
  • Autoimmune hepatitis (AIH) can arise de novo after liver transplantation (LT) for non-autoimmune liver diseases. (
  • The objectives were to assess the effects of the sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone in hepatitis B 'e' antigen positive chronic hepatitis B on mortality, virological response, biochemical response, liver histology, quality of life, and adverse events. (
  • Proceedings: Serial liver biopsies in hepatitis B antigen carriers. (
  • Hepatitis is the term for inflammation of the liver and may be due to infectious or non-infectious causes. (
  • The five types of hepatitis viruses are common infectious causes of liver inflammation, and some like hepatitis A (HAV), B (HBV) and C (HCV) are more frequently seen infectious agents. (
  • The hepatitis B virus (HBV) can infect the liver cells resulting in an acute infection or persist with chronic inflammation of the liver. (
  • Fulminant hepatitis with destruction of large parts of the liver is life-threatening. (
  • In chronic hepatitis B infection, the patient may be asymptomatic for long periods of time until there is severe damage to the liver. (
  • Chronic hepatitis B is seen where the virus does not clear and the infection persists past 6 months.The clinical features of chronic HBV infection depends on the degree of liver damage. (
  • A carrier is a person with chronic hepatitis B showing no symptoms of the infection and there is no damage to the liver. (
  • Worldwide, over 300 million persons are chronically infected with hepatitis B virus (HBV), which can cause chronic liver disease and hepatocellular carcinoma ( 22 , 35 ). (
  • Hep G2 (or HepG2) is a human liver cancer cell line. (
  • Hep G2 is an immortal cell line which was derived in 1975 from the liver tissue of a 15-year-old Caucasian male from Argentina with a well-differentiated hepatocellular carcinoma. (
  • citation needed] Hep G2 cells and their derivatives are also used as a model system for studies of liver metabolism and toxicity of xenobiotics, the detection of environmental and dietary cytotoxic and genotoxic (and thus cytoprotective, anti-genotoxic, and cogenotoxic) agents, understanding hepatocarcinogenesis[citation needed], and for drug targeting studies[citation needed]. (
  • Hep G2 cells are also employed in trials with bio-artificial liver devices[citation needed]. (
  • 8%). During delivery of recommended hepatitis B vaccination services (e.g. (
  • The duration of protection after hepatitis B vaccination in children is unknown. (
  • Integration of hepatitis B vaccination into rural African primary health care programmes. (
  • Examines the integration of hepatitis B vaccination into rural health care programs in South Africa. (
  • The primary aim of the study is to show that the antibody response to hepatitis B, acellular pertussis toxin and inactivated poliovirus antigens after the 4th vaccination with Hexavac® is not influenced by the concomitant administration of NeisVac-C. (
  • It has been reported that when hepatitis services is good throughout the territory, B vaccination is initiated at birth, there and vaccinations are delivered through local is an increased likelihood that the child health districts which are able to reach the will complete the series [ 8,9 ] hence an whole population. (
  • In this review, hepatitis B virus (HBV) and HCC prevalence, distribution and prevalence of different genotypes, and male/female infection frequencies in relation to the vaccination status in the Mediterranean countries were reported. (
  • Interferon is an established treatment for chronic infection with hepatitis B virus. (
  • The recombinant polypeptide and the single strand DNA sequence for PCR primer make it possible to detect the non-A non-B hepatitis virus with extremely high accuracy. (
  • Recombinant hepatitis B surface antigen of ayw subtype. (
  • A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance. (
  • High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B. (
  • Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment. (
  • Human leukocyte antigen (HLA) class I presents viral peptides to CD8+ T cells to permit detection of infected cells, and tapasin is an important component of the peptide loading complex for HLA class I. We sought to determine if tapasin polymorphisms affected the outcome of HCV infection. (
  • Detection of antibodies to HIV-1 gp41- and HLA class II antigen-derived peptides in SLE patients. (
  • A sensitive chemiluminescence enzyme immunoassay has been developed for hepatitis B virus (HBV) core-related antigen (HBcrAg) detection. (
  • HCV Core antigen is suitbale for ELISA and Western blots, excellent antigen for detection of HCV with minimal specificity problems. (
  • No absolute correlation between the detection of HBs Ag, or previous history of hepatitis, jaundice, or current hepatitis was found. (
  • The Hunan Jynda ELISA had the lowest sensitivity (59.5%), and the authors concluded that ELISA assays are probably a less reliable technology for HCV antigen detection than assays which use signal amplification that allows enhancement of antigen detection. (
  • HCV core-antigen can be used as a marker of viraemia as there is good non-linear correlation with HCV-RNA (r=0.87 vs. Abbot Real-Time qRT-PCR) with the lower limit of detection corresponding to HCV viral load of 700-1100 IU/ml [10]. (
  • Co-infection with hepatitis D virus (HDV) in persons with acute or chronic hepatitis B virus (HBV) infection can lead to fulminant hepatitis. (
  • About 20% to 30% of coinfections of HDV and HBV in humans develop fatal fulminant hepatitis versus 2% of patients with acute hepatitis B mono-infection. (
  • Hepatitis delta virus (HDV) causes chronic and, occasionally, fulminant hepatitis in humans ( 16 ). (
  • To develop a low cost, high compliance screening programme for identification of carriers of hepatitis B surface antigen in the obstetric population of the Netherlands. (
  • Globally, about 248 million people are chronic HBV surface antigen carriers, and about 5% of them also had hepatitis delta virus (HDV) infection as well. (
  • Twenty-five (13.3%) of the 188 individuals who were studied became chronic carriers of hepatitis B surface antigen. (
  • Among patients who were four years of age or less when infected, 28.8% became chronic carriers of hepatitis B, as compared with 7.7% of those who were 30 years of age or older. (
  • The literature is also reviewed and it is concluded that neonatal hepatitis seldom occurs in infants whose mothers have hepatitis early in pregnancy or are chronic carriers of Australia antigen. (
  • The prevalence of infection for at least 15 years, that antibody hepatitis B carriers varies in different parts levels decrease the most among persons of the world, ranging from less than 1% to immunized at 4 years of age or younger, and 15% [ 2 ]. (
  • In the Islamic Republic of Iran the level have been exposed to HBV and about 3% of antibodies to hepatitis B in vaccinated are chronic carriers, ranging from 1.7% individuals is not known. (
  • HDV is a satellite virus which requires hepatitis B virus (HBV) to supply envelope proteins for virus assembly and production ( 46 ). (
  • Viral proteins (antigens) trigger the immune system to produce corresponding antibodies. (
  • Because of their high degree of morphological and functional differentiation in vitro, Hep G2 cells are a suitable model to study the intracellular trafficking and dynamics of bile canalicular, sinusoidal membrane proteins, and lipids in human hepatocytes in vitro. (
  • HLA-DP and γ-interferon receptor-2 gene variants and their association with viral hepatitis activity in chronic hepatitis B infection. (
  • In this retrospective study, we investigated the prevalence and significance of mutations in part of the hepatitis B virus (HBV) x gene, and tried to clarify their relationship with clinicopathological or histopathological characteristics and prognosis in patients with chronic hepatitis B (CHB). (
  • We hypothesized that single-nucleotide polymorphisms (SNPs) in the gene encoding CTLA-4 may affect the vigor of the T-cell response to hepatitis B virus (HBV) infection, thus influencing viral persistence. (
  • The expression levels of the antigen in the plants grown under in vitro conditions as well as the green house hardened plants were estimated by ELISA for all the four constructs. (
  • We offer Hepatitis A Surface Antigen Antibodies for use in common research applications: ELISA, Radioimmunoassay. (
  • ELISA procedures provide a means for routinely detecting antibodies to specific antigens. (
  • The International Immunodiagnostics HDV Ab assay is a competitive enzyme immunoassay (ELISA) for the determination of antibodies to Hepatitis D Virus or HDV in human plasma and sera with a 'two step" methodology. (
  • Synergism of tapasin and human leukocyte antigens in resolving hepatitis C virus infection. (
  • Hepatitis B virus (HBV) chronically infects 300 million people worldwide, and increases their risk to develop hepatocellular carcinoma by a hundred fold [ 3 ]. (
  • Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan. (
  • Describes the prevalence of hepatitis-associated antigen (HAA) in patients with primary hepatocellular carcinoma in Taiwan. (
  • Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. (
  • This feature of the e antigen provides an assay system for laboratory diagnosis of potential clinical usefulness and suggests its possible role in pathogenesis of hepatocellular injury. (
  • Children with chronic hepatitis B (CHB) have a lifetime risk of developing hepatocellular carcinoma (HCC) up to 25% and an incidence of cirrhosis of 2-3% per year [ 1 , 2 ]. (
  • Worldwide, hepatitis B infection is one of the main causes of hepatocellular carcinoma and cirrhosis. (
  • A Systematic Review of the Current Hepatitis B Viral Infection and Hepatocellular Carcinoma Situation in Mediterranean Countries. (
  • Sera from 521 residents of an institution for the mentally retarded near Helsinki, Finland were examined by a hemagglutination assay to determine the distribution and titers of antibodies to hepatitis B surface antigen (anti-HBs). (
  • This viral capsid acts as a core antigen, the major immunodominant region lying at the tips of the alpha-helical hairpins that form spikes on the capsid surface. (
  • It contains the Hepatitis B Virus HBe adw immunodominant region. (
  • Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitope. (
  • To better define the immunological mechanisms underlying HLA-B*27-mediated protection in HCV infection, we analyzed the functional avidity, functional profile, antiviral efficacy and naïve precursor frequency of CD8+ T cells targeting the immunodominant HLA-B*27-restricted HCV-specific epitope as well as its antigen processing and presentation. (
  • Our data suggest that rapid antigen processing may be a key immunological feature of this protective and immunodominant HLA-B*27-restricted HCV-specific epitope. (
  • The review, published in Annals of Internal Medicine on 20 June, compared the sensitivity and specificity of five commercially available tests for hepatitis C core antigen compared to nucleic acid testing for HCV RNA. (
  • In this study HCV core-antigen testing on the Architect platform displayed high sensitivity (100%) and specificity (97.96%) in diagnosing acute HCV in HIV-infected individuals who experience elevated transaminases. (
  • New immunization strategies have been developed to eliminate the spread of HBV and hepatitis A virus (HAV) in the United States. (
  • Immunization against hepatitis B is an important component of preventative medicine and is offered to all children in approximately 30 countries. (
  • A Cross-Sectional Study of Anti-Hepatitis B Antibody Status in STD Patients: Need for Improved Immunization. (
  • Elimination of New Chronic Hepatitis B Virus Infections: Results of the Alaska Immunization Program. (
  • Evaluates the effectiveness of a hepatitis B immunization program in eliminating hepatitis B virus (HBV) transmission among Alaska Natives in a region in which HBV is endemic. (
  • Practices (ACIP), is the introduction of study carried out from February 2003 to hepatitis B immunization at birth [ 5,6 ]. (
  • Testing for hepatitis C virus core antigen could eventually replace the current two-step procedure for diagnosing chronic hepatitis C infection in lower- and middle-income countries, speeding up access to treatment and improving retention in care, a systematic review designed to inform World Health Organization hepatitis C testing guidelines has found. (
  • Testing for hepatitis C virus (HCV) core antigen could eventually replace the current 2-step procedure for diagnosing chronic hepatitis C infection in lower- and middle-income countries, speeding up access to treatment and improving retention in care, a systematic review designed to inform World Health Organization hepatitis C testing guidelines has found. (
  • The systematic review was not able to assess the performance of HCV antigen assays across different HCV genotypes or in HIV/HCV coinfected people due to lack of data. (
  • Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection: A Systematic Review and Meta-analysis. (
  • I am diagnosed as Hep B carrier.My test reports:HbS antigen. (
  • If your wife is at risk for hepatitis B , then the surface antigen can mean a chronic carrier state that is inactive due to no virus in her blood. (
  • Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. (
  • These findings are compared with those in three Australian antigen carrier mothers and their babies. (
  • A person with hepatitis B can be asymptomatic for long periods of time but may still be a carrier and spread the virus among different contacts. (
  • CD8+ T-cell responses to hepatitis C virus (HCV) are important in generating a successful immune response and spontaneously clearing infection. (
  • Hepatitis B viral mutants can emerge in patients as a result of selection pressure from either immune response or treatment options. (
  • Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. (
  • Replication of the hepatitis B virion is, therefore, the sole requirement for generating these nucleotide mismatch sequences. (
  • During replication, posttranscriptional RNA editing specifically modifies some of the HDV RNA, leading to the production of an elongated form of the delta antigen, the large form, which is essential for virus assembly. (
  • Prospective serological surveys of 1,280 seronegative Yupik Eskimos, performed between 1971 and 1976, identified 189 (14.8%) who developed serological evidence of hepatitis B virus infection. (
  • About 500 million individuals worldwide are infected with two major types of hepatitis B and C viruses. (
  • Thus, it is possible that V-1 Immureboost might be useful for treating hepatitis, especially when one considers the fact that immunogenic constituents of V1 are derived from HIV-infected donors many of whom are co-infected with hepatitis B and C viruses. (
  • Immunogenic components of hepatitis viruses. (
  • Unlike the surface antigen, the e-antigen is found in the blood only when there are viruses also present. (
  • Hepatitis viruses constitute a major public health problem because of the morbidity and mortality associated with the acute and chronic consequences of these infections. (
  • In addition, NHANES provides the means to better define the epidemiology of other hepatitis viruses. (
  • NHANES testing for markers of infection with hepatitis viruses will be used to determine secular trends in infection rates across most age and racial/ethnic groups, and will provide a national picture of the epidemiologic determinants of these infections. (
  • Hepatitis-Associated Antigen and Viruses. (
  • Reviews the book 'Hepatitis-Associated Antigen and Viruses,' by A. J. Zuckerman. (
  • A cross-sectional study evaluated the prevalence of and the risk factors for hepatitis C and B viruses among 700 adults above the age of 40 years in a rural area of South Korea. (
  • INTRODUCTION Co-infections between hepatitis B and HIV viruses are frequent due to their similar epidemiological characteristics. (
  • Acute Hepatitis B in a Patient with Antibodies to Hepatitis B Surface Antigen Who Was Receiving Rituximab. (
  • A letter to the editor on acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was having rituximab therapy is presented. (
  • The proportion of patients who progress to chronicity following acute hepatitis B (AHB) varies widely worldwide. (
  • Acute hepatitis with subsequent recovery and total clearance of the virus in a person with a healthy immune system. (
  • Acute hepatitis B lasts for less than 6 months. (
  • Pregnant women who are positive for hepatitis B surface antigen should be identified before delivery to prevent hepatitis B infection in their neonates by passive or active immunisation, or both. (
  • Other clinical markers aiding the hepatitis diagnosis are abnormal levels of alkaline phosphatase and bilirubin. (
  • Over the past decade, the importance of hepatitis B virus (HBV) mutants has made a transition from an academic phenomenon of unknown prevalence to a factor for consideration during disease diagnosis. (
  • The two-step diagnostic process is seen as a major obstacle to diagnosis and treatment of hepatitis C on the scale needed to achieve ambitious targets for reducing the burden of the disease and eliminating hepatitis C as a public health problem. (
  • A rapid point-of-care test for HCV antigen that could be used by health care workers in the same way as point-of-care tests for HIV or HCV antibodies was viewed as the highest priority for improving HCV diagnosis, and a feasible target for product development, by a recent stakeholder consultation convened by the Forum for Collaborative HIV Research and the Foundation for Innovative Diagnostics (FIND). (
  • HCV RNA tests can cost between $13 and $100 per test, and the cost of diagnosis and monitoring may increase the overall cost of curing hepatitis C by one-third in some settings. (
  • In this study we compare the utility of HCV core-antigen compared to qRT-PCR in the diagnosis on acute HCV in an HIV-positive cohort. (
  • In Upper Egypt, data about the prevalence, clinical, laboratory and virological characters of Hepatitis D virus-infected patients is rare. (
  • Twenty-six (13.8%) developed clinical hepatitis during the interval when seroconversion occurred. (
  • The clinical significance of persistently normal ALT in chronic hepatitis B infection. (
  • These observations suggest that the male homosexual population represents a pool of individuals within which the hepatitis B virus is readily transmitted, mainly as a subclinical infection although clinical hepatitis does occur in some patients. (
  • Pretreatment with glucocorticosteroids before treatment with alfa interferon in patients with hepatitis B 'e' antigen positive chronic hepatitis B may be more effective than treatment with alfa interferon alone with regard to loss of hepatitis B 'e' antigen and hepatitis B virus DNA, but evidence for effect on clinical outcomes is lacking. (
  • Randomised clinical trials comparing identical alfa interferon treatment regimens with and without glucocorticosteroid pretreatment for hepatitis B 'e' antigen positive chronic hepatitis. (
  • Can be used to detect antibodies to HIV, p24 antigen or other substances. (
  • Yamagiwa S, Kamimura H, Takamura M, Genda T, Ichida T, Nomoto M, Aoyagi Y. Presence of Antibodies against Self Human Leukocyte Antigen Class II Molecules in Autoimmune Hepatitis. (
  • Higher monoclonal antibody binding of 67.87% of the antigen was observed when it was expressed with a C-terminal ER retention signal. (
  • Hepatitis B Virus X antigen Monoclonal antibody specifically detects Hepatitis B Virus X antigen in Virus samples. (
  • The following antibody was used in this experiment: Hepatitis B Virus Core Antigen Monoclonal Antibody (H6F5) from Thermo Fisher Scientific, catalog # MA1-21697, RRID AB_559401. (
  • 1 2 3 Therefore, a multicentre study was designed in 1982 to determine whether efficient organisation of screening for hepatitis B could be set up in and outside hospital by adding tests for hepatitis B surface antigen to the already accepted and widely used protocol for routine antenatal screening at 14 weeks of gestation. (
  • Tapasin along with the transporter associated with antigen processing (TAP), ERp57 and calreticulin form the peptide loading complex (PLC), which loads viral peptides onto HLA class I. Tapasin binds to HLA class I and is thought to assist in the dissociation of peptides which bind with low affinity. (